ONTOLOGY REPORT - ANNOTATIONS
| Term: | testosterone |
|
| Accession: | CHEBI:17347
|
browse the term
|
| Definition: | An androstanoid having 17beta-hydroxy and 3-oxo groups, together with unsaturation at C-4-C-5. |
| Synonyms: | exact_synonym: | 17beta-hydroxyandrost-4-en-3-one |
| | related_synonym: | (8alpha,10alpha,13alpha,14beta,17alpha)-17-hydroxyandrost-4-en-3-one; 17beta-Hydroxy-4-androsten-3-one; 4-androsten-17beta-ol-3-one; Androderm; C19H28O2; InChI=1S/C19H28O2/c1-18-9-7-13(20)11-12(18)3-4-14-15-5-6-17(21)19(15,2)10-8-16(14)18/h11,14-17,21H,3-10H2,1-2H3/t14-,15-,16-,17-,18-,19-/m0/s1; InChIKey=MUMGGOZAMZWBJJ-DYKIIFRCSA-N; Testosteron; [H][C@@]12CCC3=CC(=O)CC[C@]3(C)[C@@]1([H])CC[C@]1(C)[C@@H](O)CC[C@@]21[H]; testosterona; testosteronum |
| | alt_id: | CHEBI:15214; CHEBI:26883; CHEBI:45798; CHEBI:9461 |
| | xref_casrn: | 58-22-0 |
| | xref: | Beilstein:1915399 "Beilstein Registry Number"; Beilstein:3653705 "Beilstein Registry Number"; ChEMBL:464520 "ChEMBL COMPOUND"; ChemIDplus:58-22-0 "CAS Registry Number"; CiteXplore:10438974 "PubMed citation"; DrugBank:DB00624 "DrugBank"; Gmelin:538843 "Gmelin Registry Number"; KEGG COMPOUND:58-22-0 "CAS Registry Number"; KEGG COMPOUND:C00535 "KEGG COMPOUND"; KEGG DRUG:D00075 "KEGG DRUG"; LIPID MAPS:LMST02020002 "LIPID MAPS instance" |
| | xref_mesh: | MESH:D013739 |
| | xref: | NIST Chemistry WebBook:58-22-0 "CAS Registry Number"; PDBeChem:TES "PDBeChem"; Wikipedia:Testosterone "Wikipedia" |
|
|
testosterone
|
| G |
Aacs |
acetoacetyl-CoA synthetase |
|
increases expression |
ISO |
12 |
32,206,863 |
32,250,583 |
RGD:6480464 |
CTD |
| G |
Abca1 |
ATP-binding cassette, subfamily A (ABC1), member 1 |
|
decreases expression |
ISO |
5 |
70,493,357 |
70,583,729 |
RGD:6480464 |
CTD |
| G |
Abca1 |
ATP-binding cassette, subfamily A (ABC1), member 1 |
|
multiple interactions |
EXP |
5 |
70,493,357 |
70,583,729 |
RGD:6480464 |
CTD |
| G |
Abca12 |
ATP-binding cassette, subfamily A (ABC1), member 12 |
|
decreases expression |
ISO |
9 |
70,328,327 |
70,501,128 |
RGD:6480464 |
CTD |
| G |
Abca12 |
ATP-binding cassette, subfamily A (ABC1), member 12 |
|
multiple interactions |
ISO |
9 |
70,328,327 |
70,501,128 |
RGD:6480464 |
CTD |
| G |
Abcc1 |
ATP-binding cassette, subfamily C (CFTR/MRP), member 1 |
|
multiple interactions |
ISO |
10 |
452,239 |
575,705 |
RGD:6480464 |
CTD |
| G |
Abcc1 |
ATP-binding cassette, subfamily C (CFTR/MRP), member 1 |
|
increases expression |
ISO |
10 |
452,239 |
575,705 |
RGD:6480464 |
CTD |
| G |
Abcc1 |
ATP-binding cassette, subfamily C (CFTR/MRP), member 1 |
|
affects glucuronidation |
ISO |
10 |
452,239 |
575,705 |
RGD:6480464 |
CTD |
| G |
Abcc2 |
ATP-binding cassette, subfamily C (CFTR/MRP), member 2 |
|
multiple interactions |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Abcc5 |
ATP-binding cassette, subfamily C (CFTR/MRP), member 5 |
|
decreases expression |
ISO |
11 |
82,714,334 |
82,809,354 |
RGD:6480464 |
CTD |
| G |
Abcd2 |
ATP-binding cassette, subfamily D (ALD), member 2 |
|
decreases expression |
ISO |
7 |
129,542,758 |
129,591,363 |
RGD:6480464 |
CTD |
| G |
Abcd3 |
ATP-binding cassette, subfamily D (ALD), member 3 |
|
multiple interactions |
ISO |
2 |
218,396,071 |
218,432,172 |
RGD:6480464 |
CTD |
| G |
Abcd3 |
ATP-binding cassette, subfamily D (ALD), member 3 |
|
decreases expression |
ISO |
2 |
218,396,071 |
218,432,172 |
RGD:6480464 |
CTD |
| G |
Abcg2 |
ATP-binding cassette, subfamily G (WHITE), member 2 |
|
increases expression |
ISO |
4 |
87,502,584 |
87,560,017 |
RGD:6480464 |
CTD |
| G |
Abhd16b |
abhydrolase domain containing 16B |
|
increases expression |
ISO |
3 |
170,627,853 |
170,629,750 |
RGD:6480464 |
CTD |
| G |
Abhd16b |
abhydrolase domain containing 16B |
|
multiple interactions |
ISO |
3 |
170,627,853 |
170,629,750 |
RGD:6480464 |
CTD |
| G |
Abhd3 |
abhydrolase domain containing 3 |
|
increases expression |
ISO |
18 |
2,027,477 |
2,082,082 |
RGD:6480464 |
CTD |
| G |
Abhd3 |
abhydrolase domain containing 3 |
|
multiple interactions |
ISO |
18 |
2,027,477 |
2,082,082 |
RGD:6480464 |
CTD |
| G |
Abl1 |
c-abl oncogene 1, non-receptor tyrosine kinase |
|
increases expression |
ISO |
3 |
10,804,594 |
10,907,162 |
RGD:6480464 |
CTD |
| G |
Abl1 |
c-abl oncogene 1, non-receptor tyrosine kinase |
|
multiple interactions |
ISO |
3 |
10,804,594 |
10,907,162 |
RGD:6480464 |
CTD |
| G |
Abtb1 |
ankyrin repeat and BTB (POZ) domain containing 1 |
|
multiple interactions |
ISO |
4 |
122,930,404 |
122,936,631 |
RGD:6480464 |
CTD |
| G |
Abtb1 |
ankyrin repeat and BTB (POZ) domain containing 1 |
|
increases expression |
ISO |
4 |
122,930,404 |
122,936,631 |
RGD:6480464 |
CTD |
| G |
Acaca |
acetyl-CoA carboxylase alpha |
|
increases expression |
ISO |
10 |
72,483,772 |
72,677,134 |
RGD:6480464 |
CTD |
| G |
Acadl |
acyl-CoA dehydrogenase, long chain |
|
multiple interactions |
EXP |
9 |
65,613,130 |
65,651,775 |
RGD:6480464 |
CTD |
| G |
Acadm |
acyl-CoA dehydrogenase, C-4 to C-12 straight chain |
|
multiple interactions |
ISO |
2 |
251,866,645 |
251,890,729 |
RGD:6480464 |
CTD |
| G |
Acadm |
acyl-CoA dehydrogenase, C-4 to C-12 straight chain |
|
decreases expression |
ISO |
2 |
251,866,645 |
251,890,729 |
RGD:6480464 |
CTD |
| G |
Acbd4 |
acyl-CoA binding domain containing 4 |
|
increases expression |
ISO |
10 |
92,276,972 |
92,285,988 |
RGD:6480464 |
CTD |
| G |
Acbd4 |
acyl-CoA binding domain containing 4 |
|
multiple interactions |
ISO |
10 |
92,276,972 |
92,285,988 |
RGD:6480464 |
CTD |
| G |
Acbd7 |
acyl-CoA binding domain containing 7 |
|
decreases expression |
ISO |
17 |
86,022,618 |
86,027,750 |
RGD:6480464 |
CTD |
| G |
Acbd7 |
acyl-CoA binding domain containing 7 |
|
multiple interactions |
ISO |
17 |
86,022,618 |
86,027,750 |
RGD:6480464 |
CTD |
| G |
Ace |
angiotensin I converting enzyme (peptidyl-dipeptidase A) 1 |
|
multiple interactions |
EXP |
10 |
95,361,338 |
95,381,455 |
RGD:6480464 |
CTD |
| G |
Acly |
ATP citrate lyase |
|
increases expression |
ISO |
10 |
89,420,934 |
89,471,398 |
RGD:6480464 |
CTD |
| G |
Aco2 |
aconitase 2, mitochondrial |
|
multiple interactions |
EXP |
7 |
120,223,788 |
120,266,944 |
RGD:6480464 |
CTD |
| G |
Acot11 |
acyl-CoA thioesterase 11 |
|
increases expression |
ISO |
5 |
127,820,932 |
127,870,633 |
RGD:6480464 |
CTD |
| G |
Acot11 |
acyl-CoA thioesterase 11 |
|
multiple interactions |
ISO |
5 |
127,820,932 |
127,870,633 |
RGD:6480464 |
CTD |
| G |
Acox2 |
acyl-CoA oxidase 2, branched chain |
|
multiple interactions |
ISO |
15 |
18,645,349 |
18,677,855 |
RGD:6480464 |
CTD |
| G |
Acox2 |
acyl-CoA oxidase 2, branched chain |
|
increases expression |
ISO |
15 |
18,645,349 |
18,677,855 |
RGD:6480464 |
CTD |
| G |
Acox3 |
acyl-CoA oxidase 3, pristanoyl |
|
multiple interactions |
ISO |
14 |
80,769,000 |
80,809,809 |
RGD:6480464 |
CTD |
| G |
Acox3 |
acyl-CoA oxidase 3, pristanoyl |
|
increases expression |
ISO |
14 |
80,769,000 |
80,809,809 |
RGD:6480464 |
CTD |
| G |
Acp5 |
acid phosphatase 5, tartrate resistant |
|
increases expression |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Acsl3 |
acyl-CoA synthetase long-chain family member 3 |
|
multiple interactions |
ISO |
9 |
78,083,239 |
78,106,933 |
RGD:6480464 |
CTD |
| G |
Acsl3 |
acyl-CoA synthetase long-chain family member 3 |
|
increases expression |
ISO |
9 |
78,083,239 |
78,106,933 |
RGD:6480464 |
CTD |
| G |
Acsl4 |
acyl-CoA synthetase long-chain family member 4 |
|
multiple interactions |
EXP |
X |
36,168,547 |
36,232,162 |
RGD:6480464 |
CTD |
| G |
Acss1 |
acyl-CoA synthetase short-chain family member 1 |
|
decreases expression |
ISO |
3 |
141,259,016 |
141,308,871 |
RGD:6480464 |
CTD |
| G |
Acss2 |
acyl-CoA synthetase short-chain family member 2 |
|
increases expression |
ISO |
3 |
146,013,995 |
146,057,119 |
RGD:6480464 |
CTD |
| G |
Acss3 |
acyl-CoA synthetase short-chain family member 3 |
|
multiple interactions |
ISO |
7 |
45,646,821 |
45,833,803 |
RGD:6480464 |
CTD |
| G |
Acss3 |
acyl-CoA synthetase short-chain family member 3 |
|
decreases expression |
ISO |
7 |
45,646,821 |
45,833,803 |
RGD:6480464 |
CTD |
| G |
Acta1 |
actin, alpha 1, skeletal muscle |
|
multiple interactions |
ISO |
19 |
54,081,496 |
54,084,508 |
RGD:6480464 |
CTD |
| G |
Acta1 |
actin, alpha 1, skeletal muscle |
|
increases expression |
ISO |
19 |
54,081,496 |
54,084,508 |
RGD:6480464 |
CTD |
| G |
Actg2 |
actin, gamma 2, smooth muscle, enteric |
|
multiple interactions |
ISO |
4 |
117,732,482 |
117,747,006 |
RGD:6480464 |
CTD |
| G |
Actg2 |
actin, gamma 2, smooth muscle, enteric |
|
increases expression |
ISO |
4 |
117,732,482 |
117,747,006 |
RGD:6480464 |
CTD |
| G |
Acvr2a |
activin A receptor, type IIA |
|
decreases expression |
ISO |
3 |
29,779,827 |
29,808,881 |
RGD:6480464 |
CTD |
| G |
Adam2 |
ADAM metallopeptidase domain 2 |
|
decreases expression |
ISO |
15 |
45,449,574 |
45,491,663 |
RGD:6480464 |
CTD |
| G |
Adam2 |
ADAM metallopeptidase domain 2 |
|
multiple interactions |
ISO |
15 |
45,449,574 |
45,491,663 |
RGD:6480464 |
CTD |
| G |
Adam22 |
ADAM metallopeptidase domain 22 |
|
decreases expression |
ISO |
4 |
22,332,086 |
22,507,086 |
RGD:6480464 |
CTD |
| G |
Adam22 |
ADAM metallopeptidase domain 22 |
|
multiple interactions |
ISO |
4 |
22,332,086 |
22,507,086 |
RGD:6480464 |
CTD |
| G |
Adh1 |
alcohol dehydrogenase 1 (class I) |
|
multiple interactions |
EXP |
2 |
235,799,396 |
235,811,584 |
RGD:6480464 |
CTD |
| G |
Adipoq |
adiponectin, C1Q and collagen domain containing |
|
decreases expression |
ISO |
11 |
79,908,291 |
79,911,065 |
RGD:6480464 |
CTD |
| G |
Adnp2 |
ADNP homeobox 2 |
|
decreases expression |
ISO |
18 |
77,017,502 |
77,041,570 |
RGD:6480464 |
CTD |
| G |
Adora1 |
adenosine A1 receptor |
|
multiple interactions |
ISO |
13 |
47,160,292 |
47,192,804 |
RGD:6480464 |
CTD |
| G |
Adora1 |
adenosine A1 receptor |
|
decreases expression |
ISO |
13 |
47,160,292 |
47,192,804 |
RGD:6480464 |
CTD |
| G |
Adora2b |
adenosine A2B receptor |
|
decreases expression |
ISO |
10 |
48,421,592 |
48,437,967 |
RGD:6480464 |
CTD |
| G |
Adora2b |
adenosine A2B receptor |
|
multiple interactions |
ISO |
10 |
48,421,592 |
48,437,967 |
RGD:6480464 |
CTD |
| G |
Adra1a |
adrenoceptor alpha 1A |
|
increases expression |
EXP |
15 |
46,173,429 |
46,263,198 |
RGD:6480464 |
CTD |
| G |
Adra1b |
adrenoceptor alpha 1B |
|
affects expression |
EXP |
10 |
28,889,092 |
28,946,889 |
RGD:6480464 |
CTD |
| G |
Adra2a |
adrenoceptor alpha 2A |
|
increases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Adrb1 |
adrenoceptor beta 1 |
|
increases expression |
EXP |
1 |
263,025,655 |
263,027,055 |
RGD:6480464 |
CTD |
| G |
Aff3 |
AF4/FMR2 family, member 3 |
|
multiple interactions |
ISO |
9 |
37,121,330 |
37,516,836 |
RGD:6480464 |
CTD |
| G |
Aff3 |
AF4/FMR2 family, member 3 |
|
increases expression |
ISO |
9 |
37,121,330 |
37,516,836 |
RGD:6480464 |
CTD |
| G |
Agr2 |
anterior gradient 2 homolog (Xenopus laevis) |
|
multiple interactions |
ISO |
6 |
54,695,633 |
54,716,858 |
RGD:6480464 |
CTD |
| G |
Agr2 |
anterior gradient 2 homolog (Xenopus laevis) |
|
increases expression |
ISO |
6 |
54,695,633 |
54,716,858 |
RGD:6480464 |
CTD |
| G |
Agr2 |
anterior gradient 2 homolog (Xenopus laevis) |
|
affects expression |
ISO |
6 |
54,695,633 |
54,716,858 |
RGD:6480464 |
CTD |
| G |
Agt |
angiotensinogen (serpin peptidase inhibitor, clade A, member 8) |
|
increases expression |
EXP |
19 |
54,738,556 |
54,750,349 |
RGD:6480464 |
CTD |
| G |
Agtr2 |
angiotensin II receptor, type 2 |
|
affects expression |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Agxt2l2 |
alanine-glyoxylate aminotransferase 2-like 2 |
|
multiple interactions |
ISO |
10 |
37,100,238 |
37,117,744 |
RGD:6480464 |
CTD |
| G |
Agxt2l2 |
alanine-glyoxylate aminotransferase 2-like 2 |
|
increases expression |
ISO |
10 |
37,100,238 |
37,117,744 |
RGD:6480464 |
CTD |
| G |
Agxt2l2 |
alanine-glyoxylate aminotransferase 2-like 2 |
|
affects expression |
ISO |
10 |
37,100,238 |
37,117,744 |
RGD:6480464 |
CTD |
| G |
Ahcyl1 |
adenosylhomocysteinase-like 1 |
|
decreases expression |
ISO |
2 |
203,210,376 |
203,244,218 |
RGD:6480464 |
CTD |
| G |
Ahnak |
AHNAK nucleoprotein |
|
multiple interactions |
ISO |
1 |
211,662,523 |
211,692,558 |
RGD:6480464 |
CTD |
| G |
Ahnak |
AHNAK nucleoprotein |
|
increases expression |
ISO |
1 |
211,662,523 |
211,692,558 |
RGD:6480464 |
CTD |
| G |
Ahr |
aryl hydrocarbon receptor |
|
increases expression |
ISO |
6 |
54,205,104 |
54,240,268 |
RGD:6480464 |
CTD |
| G |
Ak3 |
adenylate kinase 3 |
|
decreases expression |
ISO |
1 |
232,658,879 |
232,684,083 |
RGD:6480464 |
CTD |
| G |
Akap12 |
A kinase (PRKA) anchor protein 12 |
|
multiple interactions |
ISO |
1 |
34,979,039 |
35,068,763 |
RGD:6480464 |
CTD |
| G |
Akap12 |
A kinase (PRKA) anchor protein 12 |
|
increases expression |
ISO |
1 |
34,979,039 |
35,068,763 |
RGD:6480464 |
CTD |
| G |
Akr1c1 |
aldo-keto reductase family 1, member C1 |
|
multiple interactions |
ISO |
17 |
77,084,306 |
77,112,994 |
RGD:6480464 |
CTD |
| G |
Akr1c1 |
aldo-keto reductase family 1, member C1 |
|
increases expression |
ISO |
17 |
77,084,306 |
77,112,994 |
RGD:6480464 |
CTD |
| G |
Akr1c1 |
aldo-keto reductase family 1, member C1 |
|
increases oxidation |
EXP |
17 |
77,084,306 |
77,112,994 |
RGD:6480464 |
CTD |
| G |
Akr1c3 |
aldo-keto reductase family 1, member C3 |
|
increases abundance |
ISO |
17 |
77,269,626 |
77,286,521 |
RGD:6480464 |
CTD |
| G |
Akr1c3 |
aldo-keto reductase family 1, member C3 |
|
multiple interactions |
ISO |
17 |
77,269,626 |
77,286,521 |
RGD:6480464 |
CTD |
| G |
Akr1d1 |
aldo-keto reductase family 1, member D1 |
|
decreases expression |
ISO |
4 |
64,972,908 |
65,005,896 |
RGD:6480464 |
CTD |
| G |
Akt1 |
v-akt murine thymoma viral oncogene homolog 1 |
|
multiple interactions |
ISO |
6 |
137,640,482 |
137,657,552 |
RGD:6480464 |
CTD |
| G |
Akt1 |
v-akt murine thymoma viral oncogene homolog 1 |
|
increases phosphorylation |
ISO |
6 |
137,640,482 |
137,657,552 |
RGD:6480464 |
CTD |
| G |
Akt1 |
v-akt murine thymoma viral oncogene homolog 1 |
|
decreases phosphorylation |
ISO |
6 |
137,640,482 |
137,657,552 |
RGD:6480464 |
CTD |
| G |
Akt1 |
v-akt murine thymoma viral oncogene homolog 1 |
|
multiple interactions |
ISO |
6 |
137,640,482 |
137,657,552 |
RGD:6480464 |
CTD |
| G |
Akt1 |
v-akt murine thymoma viral oncogene homolog 1 |
|
decreases phosphorylation |
ISO |
6 |
137,640,482 |
137,657,552 |
RGD:6480464 |
CTD |
| G |
Akt1 |
v-akt murine thymoma viral oncogene homolog 1 |
|
increases activity |
EXP |
6 |
137,640,482 |
137,657,552 |
RGD:6480464 |
CTD |
| G |
Akt1 |
v-akt murine thymoma viral oncogene homolog 1 |
|
multiple interactions |
EXP |
6 |
137,640,482 |
137,657,552 |
RGD:6480464 |
CTD |
| G |
Akt1 |
v-akt murine thymoma viral oncogene homolog 1 |
|
multiple interactions |
EXP |
6 |
137,640,482 |
137,657,552 |
RGD:6480464 |
CTD |
| G |
Akt2 |
v-akt murine thymoma viral oncogene homolog 2 |
|
increases expression |
ISO |
1 |
82,686,233 |
82,726,544 |
RGD:6480464 |
CTD |
| G |
Alas1 |
aminolevulinate, delta-, synthase 1 |
|
increases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Alas2 |
aminolevulinate, delta-, synthase 2 |
|
increases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Aldh1a1 |
aldehyde dehydrogenase 1 family, member A1 |
|
increases expression |
ISO |
1 |
223,731,675 |
223,773,285 |
RGD:6480464 |
CTD |
| G |
Aldh1a3 |
aldehyde dehydrogenase 1 family, member A3 |
|
multiple interactions |
ISO |
1 |
120,847,746 |
120,881,883 |
RGD:6480464 |
CTD |
| G |
Aldh1a3 |
aldehyde dehydrogenase 1 family, member A3 |
|
increases expression |
ISO |
1 |
120,847,746 |
120,881,883 |
RGD:6480464 |
CTD |
| G |
Aldh4a1 |
aldehyde dehydrogenase 4 family, member A1 |
|
multiple interactions |
ISO |
5 |
158,437,691 |
158,453,827 |
RGD:6480464 |
CTD |
| G |
Aldh4a1 |
aldehyde dehydrogenase 4 family, member A1 |
|
increases expression |
ISO |
5 |
158,437,691 |
158,453,827 |
RGD:6480464 |
CTD |
| G |
Alpp |
alkaline phosphatase, placental |
|
increases chemical synthesis |
ISO |
9 |
85,885,336 |
85,888,082 |
RGD:6480464 |
CTD |
| G |
Ampd3 |
adenosine monophosphate deaminase 3 |
|
multiple interactions |
EXP |
1 |
168,519,462 |
168,568,291 |
RGD:6480464 |
CTD |
| G |
Angpt2 |
angiopoietin 2 |
|
multiple interactions |
ISO |
16 |
75,891,757 |
75,942,255 |
RGD:6480464 |
CTD |
| G |
Angptl2 |
angiopoietin-like 2 |
|
decreases expression |
ISO |
3 |
12,226,515 |
12,256,396 |
RGD:6480464 |
CTD |
| G |
Angptl4 |
angiopoietin-like 4 |
|
multiple interactions |
EXP |
7 |
16,261,623 |
16,267,852 |
RGD:6480464 |
CTD |
| G |
Angptl6 |
angiopoietin-like 6 |
|
affects expression |
ISO |
8 |
19,899,121 |
19,905,696 |
RGD:6480464 |
CTD |
| G |
Ank1 |
ankyrin 1, erythrocytic |
|
increases expression |
ISO |
16 |
73,333,564 |
73,437,926 |
RGD:6480464 |
CTD |
| G |
Ank1 |
ankyrin 1, erythrocytic |
|
multiple interactions |
EXP |
16 |
73,333,564 |
73,437,926 |
RGD:6480464 |
CTD |
| G |
Ank1 |
ankyrin 1, erythrocytic |
|
multiple interactions |
ISO |
16 |
73,333,564 |
73,437,926 |
RGD:6480464 |
CTD |
| G |
Ankh |
ankylosis, progressive homolog (mouse) |
|
multiple interactions |
ISO |
2 |
79,289,427 |
79,418,518 |
RGD:6480464 |
CTD |
| G |
Ankh |
ankylosis, progressive homolog (mouse) |
|
increases expression |
ISO |
2 |
79,289,427 |
79,418,518 |
RGD:6480464 |
CTD |
| G |
Ankrd12 |
ankyrin repeat domain 12 |
|
decreases expression |
ISO |
9 |
104,746,476 |
104,823,263 |
RGD:6480464 |
CTD |
| G |
Ankrd2 |
ankyrin repeat domain 2 (stretch responsive muscle) |
|
increases expression |
ISO |
1 |
248,806,966 |
248,816,413 |
RGD:6480464 |
CTD |
| G |
Ankrd22 |
ankyrin repeat domain 22 |
|
multiple interactions |
ISO |
1 |
237,986,215 |
238,017,941 |
RGD:6480464 |
CTD |
| G |
Ankrd22 |
ankyrin repeat domain 22 |
|
increases expression |
ISO |
1 |
237,986,215 |
238,017,941 |
RGD:6480464 |
CTD |
| G |
Ankrd37 |
ankyrin repeat domain 37 |
|
increases expression |
ISO |
16 |
49,549,527 |
49,552,416 |
RGD:6480464 |
CTD |
| G |
Ankrd37 |
ankyrin repeat domain 37 |
|
multiple interactions |
ISO |
16 |
49,549,527 |
49,552,416 |
RGD:6480464 |
CTD |
| G |
Anln |
anillin, actin binding protein |
|
multiple interactions |
ISO |
8 |
21,642,021 |
21,721,815 |
RGD:6480464 |
CTD |
| G |
Anln |
anillin, actin binding protein |
|
decreases expression |
ISO |
8 |
21,642,021 |
21,721,815 |
RGD:6480464 |
CTD |
| G |
Anlnl1 |
anillin, actin binding protein-like 1 |
|
multiple interactions |
ISO |
17 |
68,547,371 |
68,559,629 |
RGD:6480464 |
CTD |
| G |
Anlnl1 |
anillin, actin binding protein-like 1 |
|
decreases expression |
ISO |
17 |
68,547,371 |
68,559,629 |
RGD:6480464 |
CTD |
| G |
Ano10 |
anoctamin 10 |
|
multiple interactions |
ISO |
8 |
121,978,317 |
122,095,649 |
RGD:6480464 |
CTD |
| G |
Ano10 |
anoctamin 10 |
|
increases expression |
ISO |
8 |
121,978,317 |
122,095,649 |
RGD:6480464 |
CTD |
| G |
Anp32e |
acidic (leucine-rich) nuclear phosphoprotein 32 family, member E |
|
multiple interactions |
ISO |
2 |
190,715,685 |
190,730,204 |
RGD:6480464 |
CTD |
| G |
Anp32e |
acidic (leucine-rich) nuclear phosphoprotein 32 family, member E |
|
decreases expression |
ISO |
2 |
190,715,685 |
190,730,204 |
RGD:6480464 |
CTD |
| G |
Antxr1 |
anthrax toxin receptor 1 |
|
multiple interactions |
ISO |
4 |
121,297,955 |
121,483,876 |
RGD:6480464 |
CTD |
| G |
Antxr1 |
anthrax toxin receptor 1 |
|
decreases expression |
ISO |
4 |
121,297,955 |
121,483,876 |
RGD:6480464 |
CTD |
| G |
Anxa2 |
annexin A2 |
|
multiple interactions |
ISO |
8 |
73,897,618 |
73,934,041 |
RGD:6480464 |
CTD |
| G |
Anxa2 |
annexin A2 |
|
increases expression |
ISO |
8 |
73,897,618 |
73,934,041 |
RGD:6480464 |
CTD |
| G |
Anxa3 |
annexin A3 |
|
multiple interactions |
ISO |
14 |
14,245,112 |
14,297,100 |
RGD:6480464 |
CTD |
| G |
Anxa3 |
annexin A3 |
|
increases expression |
ISO |
14 |
14,245,112 |
14,297,100 |
RGD:6480464 |
CTD |
| G |
Aox1 |
aldehyde oxidase 1 |
|
increases expression |
ISO |
9 |
56,693,698 |
56,774,115 |
RGD:6480464 |
CTD |
| G |
Aox1 |
aldehyde oxidase 1 |
|
multiple interactions |
EXP |
9 |
56,693,698 |
56,774,115 |
RGD:6480464 |
CTD |
| G |
Aox3 |
aldehyde oxidase 3 |
|
increases expression |
ISO |
9 |
56,779,880 |
56,867,683 |
RGD:6480464 |
CTD |
| G |
Ap3m1 |
adaptor-related protein complex 3, mu 1 subunit |
|
decreases expression |
ISO |
15 |
3,459,364 |
3,477,284 |
RGD:6480464 |
CTD |
| G |
Aph1b |
anterior pharynx defective 1 homolog B (C. elegans) |
|
multiple interactions |
ISO |
8 |
71,122,681 |
71,143,726 |
RGD:6480464 |
CTD |
| G |
Aph1b |
anterior pharynx defective 1 homolog B (C. elegans) |
|
increases expression |
ISO |
8 |
71,122,681 |
71,143,726 |
RGD:6480464 |
CTD |
| G |
Apln |
apelin |
|
multiple interactions |
EXP |
X |
134,387,285 |
134,396,762 |
RGD:6480464 |
CTD |
| G |
Aplp2 |
amyloid beta (A4) precursor-like protein 2 |
|
decreases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Apobec3b |
apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3B |
|
multiple interactions |
ISO |
7 |
118,121,580 |
118,140,691 |
RGD:6480464 |
CTD |
| G |
Apobec3b |
apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3B |
|
decreases expression |
ISO |
7 |
118,121,580 |
118,140,691 |
RGD:6480464 |
CTD |
| G |
Apoc3 |
apolipoprotein C-III |
|
multiple interactions |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Apof |
apolipoprotein F |
|
multiple interactions |
ISO |
7 |
1,562,515 |
1,563,953 |
RGD:6480464 |
CTD |
| G |
Apof |
apolipoprotein F |
|
increases expression |
ISO |
7 |
1,562,515 |
1,563,953 |
RGD:6480464 |
CTD |
| G |
Appbp2 |
amyloid beta precursor protein (cytoplasmic tail) binding protein 2 |
|
multiple interactions |
ISO |
10 |
73,460,120 |
73,502,173 |
RGD:6480464 |
CTD |
| G |
Appbp2 |
amyloid beta precursor protein (cytoplasmic tail) binding protein 2 |
|
increases expression |
ISO |
10 |
73,460,120 |
73,502,173 |
RGD:6480464 |
CTD |
| G |
Aqp9 |
aquaporin 9 |
|
decreases expression |
ISO |
8 |
75,611,485 |
75,651,646 |
RGD:6480464 |
CTD |
| G |
Ar |
androgen receptor |
|
multiple interactions |
ISO |
X |
85,949,507 |
86,119,199 |
RGD:6480464 |
CTD |
| G |
Ar |
androgen receptor |
|
affects abundance |
ISO |
X |
85,949,507 |
86,119,199 |
RGD:6480464 |
CTD |
| G |
Ar |
androgen receptor |
|
affects response to substance |
ISO |
X |
85,949,507 |
86,119,199 |
RGD:6480464 |
CTD |
| G |
Ar |
androgen receptor |
|
affects response to substance |
ISO |
X |
85,949,507 |
86,119,199 |
RGD:6480464 |
CTD |
| G |
Ar |
androgen receptor |
|
multiple interactions |
ISO |
X |
85,949,507 |
86,119,199 |
RGD:6480464 |
CTD |
| G |
Ar |
androgen receptor |
|
multiple interactions |
ISO |
X |
85,949,507 |
86,119,199 |
RGD:6480464 |
CTD |
| G |
Ar |
androgen receptor |
|
multiple interactions |
ISO |
X |
85,949,507 |
86,119,199 |
RGD:6480464 |
CTD |
| G |
Ar |
androgen receptor |
|
multiple interactions |
ISO |
X |
85,949,507 |
86,119,199 |
RGD:6480464 |
CTD |
| G |
Ar |
androgen receptor |
|
multiple interactions |
ISO |
X |
85,949,507 |
86,119,199 |
RGD:6480464 |
CTD |
| G |
Ar |
androgen receptor |
|
multiple interactions |
ISO |
X |
85,949,507 |
86,119,199 |
RGD:6480464 |
CTD |
| G |
Ar |
androgen receptor |
|
multiple interactions |
ISO |
X |
85,949,507 |
86,119,199 |
RGD:6480464 |
CTD |
| G |
Ar |
androgen receptor |
|
multiple interactions |
ISO |
X |
85,949,507 |
86,119,199 |
RGD:6480464 |
CTD |
| G |
Ar |
androgen receptor |
|
affects binding |
ISO |
X |
85,949,507 |
86,119,199 |
RGD:6480464 |
CTD |
| G |
Ar |
androgen receptor |
|
increases activity |
ISO |
X |
85,949,507 |
86,119,199 |
RGD:6480464 |
CTD |
| G |
Ar |
androgen receptor |
|
increases expression |
ISO |
X |
85,949,507 |
86,119,199 |
RGD:6480464 |
CTD |
| G |
Ar |
androgen receptor |
|
multiple interactions |
ISO |
X |
85,949,507 |
86,119,199 |
RGD:6480464 |
CTD |
| G |
Ar |
androgen receptor |
|
multiple interactions |
ISO |
X |
85,949,507 |
86,119,199 |
RGD:6480464 |
CTD |
| G |
Ar |
androgen receptor |
|
increases expression |
ISO |
X |
85,949,507 |
86,119,199 |
RGD:6480464 |
CTD |
| G |
Ar |
androgen receptor |
|
decreases expression |
ISO |
X |
85,949,507 |
86,119,199 |
RGD:6480464 |
CTD |
| G |
Ar |
androgen receptor |
|
multiple interactions |
ISO |
X |
85,949,507 |
86,119,199 |
RGD:6480464 |
CTD |
| G |
Ar |
androgen receptor |
|
increases expression |
ISO |
X |
85,949,507 |
86,119,199 |
RGD:6480464 |
CTD |
| G |
Ar |
androgen receptor |
|
increases expression |
ISO |
X |
85,949,507 |
86,119,199 |
RGD:6480464 |
CTD |
| G |
Ar |
androgen receptor |
|
multiple interactions |
EXP |
X |
85,949,507 |
86,119,199 |
RGD:6480464 |
CTD |
| G |
Ar |
androgen receptor |
|
multiple interactions |
EXP |
X |
85,949,507 |
86,119,199 |
RGD:6480464 |
CTD |
| G |
Ar |
androgen receptor |
|
multiple interactions |
EXP |
X |
85,949,507 |
86,119,199 |
RGD:6480464 |
CTD |
| G |
Ar |
androgen receptor |
|
multiple interactions |
EXP |
X |
85,949,507 |
86,119,199 |
RGD:6480464 |
CTD |
| G |
Ar |
androgen receptor |
|
multiple interactions |
EXP |
X |
85,949,507 |
86,119,199 |
RGD:6480464 |
CTD |
| G |
Ar |
androgen receptor |
|
multiple interactions |
EXP |
X |
85,949,507 |
86,119,199 |
RGD:6480464 |
CTD |
| G |
Ar |
androgen receptor |
|
affects expression |
EXP |
X |
85,949,507 |
86,119,199 |
RGD:6480464 |
CTD |
| G |
Ar |
androgen receptor |
|
multiple interactions |
EXP |
X |
85,949,507 |
86,119,199 |
RGD:6480464 |
CTD |
| G |
Ar |
androgen receptor |
|
affects localization |
EXP |
X |
85,949,507 |
86,119,199 |
RGD:6480464 |
CTD |
| G |
Ar |
androgen receptor |
|
affects binding |
EXP |
X |
85,949,507 |
86,119,199 |
RGD:6480464 |
CTD |
| G |
Ar |
androgen receptor |
|
multiple interactions |
EXP |
X |
85,949,507 |
86,119,199 |
RGD:6480464 |
CTD |
| G |
Ar |
androgen receptor |
|
increases expression |
EXP |
X |
85,949,507 |
86,119,199 |
RGD:6480464 |
CTD |
| G |
Ar |
androgen receptor |
|
multiple interactions |
EXP |
X |
85,949,507 |
86,119,199 |
RGD:6480464 |
CTD |
| G |
Arap2 |
ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 2 |
|
multiple interactions |
ISO |
14 |
50,594,829 |
50,789,829 |
RGD:6480464 |
CTD |
| G |
Arap2 |
ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 2 |
|
increases expression |
ISO |
14 |
50,594,829 |
50,789,829 |
RGD:6480464 |
CTD |
| G |
Arg1 |
arginase, liver |
|
multiple interactions |
ISO |
1 |
20,998,894 |
21,011,275 |
RGD:6480464 |
CTD |
| G |
Arg1 |
arginase, liver |
|
increases expression |
ISO |
1 |
20,998,894 |
21,011,275 |
RGD:6480464 |
CTD |
| G |
Arg2 |
arginase type II |
|
multiple interactions |
EXP |
6 |
101,901,653 |
101,928,282 |
RGD:6480464 |
CTD |
| G |
Arhgap11a |
Rho GTPase activating protein 11A |
|
multiple interactions |
ISO |
3 |
99,676,951 |
99,693,232 |
RGD:6480464 |
CTD |
| G |
Arhgap11a |
Rho GTPase activating protein 11A |
|
decreases expression |
ISO |
3 |
99,676,951 |
99,693,232 |
RGD:6480464 |
CTD |
| G |
Arhgef18 |
rho/rac guanine nucleotide exchange factor (GEF) 18 |
|
multiple interactions |
ISO |
12 |
2,712,198 |
2,855,137 |
RGD:6480464 |
CTD |
| G |
Arhgef18 |
rho/rac guanine nucleotide exchange factor (GEF) 18 |
|
increases expression |
ISO |
12 |
2,712,198 |
2,855,137 |
RGD:6480464 |
CTD |
| G |
Arhgef37 |
Rho guanine nucleotide exchange factor (GEF) 37 |
|
multiple interactions |
ISO |
18 |
57,473,010 |
57,524,775 |
RGD:6480464 |
CTD |
| G |
Arhgef37 |
Rho guanine nucleotide exchange factor (GEF) 37 |
|
increases expression |
ISO |
18 |
57,473,010 |
57,524,775 |
RGD:6480464 |
CTD |
| G |
Arhgef39 |
Rho guanine nucleotide exchange factor (GEF) 39 |
|
multiple interactions |
ISO |
5 |
59,977,497 |
59,979,258 |
RGD:6480464 |
CTD |
| G |
Arhgef39 |
Rho guanine nucleotide exchange factor (GEF) 39 |
|
decreases expression |
ISO |
5 |
59,977,497 |
59,979,258 |
RGD:6480464 |
CTD |
| G |
Arl6ip6 |
ADP-ribosylation-like factor 6 interacting protein 6 |
|
multiple interactions |
ISO |
3 |
34,722,398 |
34,748,336 |
RGD:6480464 |
CTD |
| G |
Arl6ip6 |
ADP-ribosylation-like factor 6 interacting protein 6 |
|
decreases expression |
ISO |
3 |
34,722,398 |
34,748,336 |
RGD:6480464 |
CTD |
| G |
Armc7 |
armadillo repeat containing 7 |
|
multiple interactions |
ISO |
10 |
105,558,266 |
105,574,799 |
RGD:6480464 |
CTD |
| G |
Armc7 |
armadillo repeat containing 7 |
|
increases expression |
ISO |
10 |
105,558,266 |
105,574,799 |
RGD:6480464 |
CTD |
| G |
Armcx3 |
armadillo repeat containing, X-linked 3 |
|
increases expression |
ISO |
X |
122,217,524 |
122,221,077 |
RGD:6480464 |
CTD |
| G |
Arpc1b |
actin related protein 2/3 complex, subunit 1B |
|
multiple interactions |
ISO |
12 |
9,796,269 |
9,803,639 |
RGD:6480464 |
CTD |
| G |
Arpc1b |
actin related protein 2/3 complex, subunit 1B |
|
increases expression |
ISO |
12 |
9,796,269 |
9,803,639 |
RGD:6480464 |
CTD |
| G |
Arrdc3 |
arrestin domain containing 3 |
|
multiple interactions |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Arrdc3 |
arrestin domain containing 3 |
|
decreases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Arrdc4 |
arrestin domain containing 4 |
|
decreases expression |
ISO |
1 |
123,522,706 |
123,531,698 |
RGD:6480464 |
CTD |
| G |
Arsa |
arylsulfatase A |
|
multiple interactions |
ISO |
7 |
127,790,208 |
127,792,734 |
RGD:6480464 |
CTD |
| G |
Arsa |
arylsulfatase A |
|
increases expression |
ISO |
7 |
127,790,208 |
127,792,734 |
RGD:6480464 |
CTD |
| G |
Art1 |
ADP-ribosyltransferase 1 |
|
multiple interactions |
EXP |
1 |
159,586,246 |
159,590,797 |
RGD:6480464 |
CTD |
| G |
Art5 |
ADP-ribosyltransferase 5 |
|
multiple interactions |
EXP |
1 |
159,576,990 |
159,586,949 |
RGD:6480464 |
CTD |
| G |
Asah2 |
N-acylsphingosine amidohydrolase (non-lysosomal ceramidase) 2 |
|
multiple interactions |
EXP |
1 |
236,000,768 |
236,072,477 |
RGD:6480464 |
CTD |
| G |
Asb13 |
ankyrin repeat and SOCS box-containing 13 |
|
increases expression |
ISO |
17 |
77,759,058 |
77,777,760 |
RGD:6480464 |
CTD |
| G |
Asf1b |
ASF1 anti-silencing function 1 homolog B (S. cerevisiae) |
|
multiple interactions |
ISO |
19 |
25,867,384 |
25,881,909 |
RGD:6480464 |
CTD |
| G |
Asnsd1 |
asparagine synthetase domain containing 1 |
|
multiple interactions |
ISO |
9 |
45,071,438 |
45,089,056 |
RGD:6480464 |
CTD |
| G |
Atf6b |
activating transcription factor 6 beta |
|
decreases expression |
ISO |
20 |
4,192,185 |
4,200,036 |
RGD:6480464 |
CTD |
| G |
Atm |
ataxia telangiectasia mutated |
|
affects expression |
ISO |
8 |
56,894,746 |
56,996,565 |
RGD:6480464 |
CTD |
| G |
Atp1a2 |
ATPase, Na+/K+ transporting, alpha 2 polypeptide |
|
multiple interactions |
ISO |
13 |
88,258,993 |
88,283,918 |
RGD:6480464 |
CTD |
| G |
Atp1a2 |
ATPase, Na+/K+ transporting, alpha 2 polypeptide |
|
increases expression |
ISO |
13 |
88,258,993 |
88,283,918 |
RGD:6480464 |
CTD |
| G |
Atp1b1 |
ATPase, Na+/K+ transporting, beta 1 polypeptide |
|
decreases expression |
ISO |
13 |
80,214,056 |
80,234,576 |
RGD:6480464 |
CTD |
| G |
Atp1b1 |
ATPase, Na+/K+ transporting, beta 1 polypeptide |
|
multiple interactions |
ISO |
13 |
80,214,056 |
80,234,576 |
RGD:6480464 |
CTD |
| G |
Atp1b2 |
ATPase, Na+/K+ transporting, beta 2 polypeptide |
|
decreases expression |
ISO |
10 |
56,418,323 |
56,424,465 |
RGD:6480464 |
CTD |
| G |
Atp2b1 |
ATPase, Ca++ transporting, plasma membrane 1 |
|
multiple interactions |
ISO |
7 |
36,493,661 |
36,600,280 |
RGD:6480464 |
CTD |
| G |
Atp2b1 |
ATPase, Ca++ transporting, plasma membrane 1 |
|
decreases expression |
ISO |
7 |
36,493,661 |
36,600,280 |
RGD:6480464 |
CTD |
| G |
Atp2b1 |
ATPase, Ca++ transporting, plasma membrane 1 |
|
increases expression |
ISO |
7 |
36,493,661 |
36,600,280 |
RGD:6480464 |
CTD |
| G |
Atp5b |
ATP synthase, H+ transporting, mitochondrial F1 complex, beta polypeptide |
|
decreases expression |
ISO |
7 |
1,376,552 |
1,383,228 |
RGD:6480464 |
CTD |
| G |
Atp5b |
ATP synthase, H+ transporting, mitochondrial F1 complex, beta polypeptide |
|
multiple interactions |
ISO |
7 |
1,376,552 |
1,383,228 |
RGD:6480464 |
CTD |
| G |
Atp6v0a2 |
ATPase, H+ transporting, lysosomal V0 subunit A2 |
|
affects expression |
ISO |
12 |
33,061,611 |
33,092,421 |
RGD:6480464 |
CTD |
| G |
Atp6v1b2 |
ATPase, H transporting, lysosomal V1 subunit B2 |
|
multiple interactions |
EXP |
16 |
22,320,425 |
22,344,445 |
RGD:6480464 |
CTD |
| G |
Atp8a1 |
ATPase, aminophospholipid transporter (APLT), class I, type 8A, member 1 |
|
multiple interactions |
ISO |
14 |
42,923,309 |
43,165,666 |
RGD:6480464 |
CTD |
| G |
Atp8a1 |
ATPase, aminophospholipid transporter (APLT), class I, type 8A, member 1 |
|
increases expression |
ISO |
14 |
42,923,309 |
43,165,666 |
RGD:6480464 |
CTD |
| G |
Atxn7l2 |
ataxin 7-like 2 |
|
multiple interactions |
ISO |
2 |
203,767,580 |
203,776,399 |
RGD:6480464 |
CTD |
| G |
Atxn7l2 |
ataxin 7-like 2 |
|
decreases expression |
ISO |
2 |
203,767,580 |
203,776,399 |
RGD:6480464 |
CTD |
| G |
Aunip |
aurora kinase A and ninein interacting protein |
|
multiple interactions |
ISO |
5 |
153,267,331 |
153,280,190 |
RGD:6480464 |
CTD |
| G |
Aunip |
aurora kinase A and ninein interacting protein |
|
decreases expression |
ISO |
5 |
153,267,331 |
153,280,190 |
RGD:6480464 |
CTD |
| G |
Aurka |
aurora kinase A |
|
multiple interactions |
ISO |
3 |
163,270,479 |
163,284,506 |
RGD:6480464 |
CTD |
| G |
Aurka |
aurora kinase A |
|
decreases expression |
ISO |
3 |
163,270,479 |
163,284,506 |
RGD:6480464 |
CTD |
| G |
Aurkb |
aurora kinase B |
|
decreases expression |
ISO |
10 |
55,798,710 |
55,804,367 |
RGD:6480464 |
CTD |
| G |
Aurkb |
aurora kinase B |
|
multiple interactions |
ISO |
10 |
55,798,710 |
55,804,367 |
RGD:6480464 |
CTD |
| G |
Avp |
arginine vasopressin |
|
affects expression |
EXP |
3 |
118,205,007 |
118,206,985 |
RGD:6480464 |
CTD |
| G |
Azgp1 |
alpha-2-glycoprotein 1, zinc-binding |
|
affects expression |
ISO |
12 |
17,492,913 |
17,498,949 |
RGD:6480464 |
CTD |
| G |
B3galt4 |
UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase, polypeptide 4 |
|
multiple interactions |
ISO |
20 |
5,087,855 |
5,089,430 |
RGD:6480464 |
CTD |
| G |
B3galt4 |
UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase, polypeptide 4 |
|
increases expression |
ISO |
20 |
5,087,855 |
5,089,430 |
RGD:6480464 |
CTD |
| G |
B3gnt2 |
UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 2 |
|
multiple interactions |
ISO |
14 |
103,499,471 |
103,524,296 |
RGD:6480464 |
CTD |
| G |
B3gnt2 |
UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 2 |
|
increases expression |
ISO |
14 |
103,499,471 |
103,524,296 |
RGD:6480464 |
CTD |
| G |
B4galt6 |
UDP-Gal:betaGlcNAc beta 1,4-galactosyltransferase, polypeptide 6 |
|
multiple interactions |
EXP |
18 |
12,421,062 |
12,478,276 |
RGD:6480464 |
CTD |
| G |
Bad |
BCL2-associated agonist of cell death |
|
increases expression |
EXP |
1 |
209,617,373 |
209,626,292 |
RGD:6480464 |
CTD |
| G |
Bai2 |
brain-specific angiogenesis inhibitor 2 |
|
multiple interactions |
ISO |
5 |
149,014,053 |
149,046,244 |
RGD:6480464 |
CTD |
| G |
Bai2 |
brain-specific angiogenesis inhibitor 2 |
|
decreases expression |
ISO |
5 |
149,014,053 |
149,046,244 |
RGD:6480464 |
CTD |
| G |
Bard1 |
BRCA1 associated RING domain 1 |
|
multiple interactions |
ISO |
9 |
70,120,151 |
70,198,591 |
RGD:6480464 |
CTD |
| G |
Bard1 |
BRCA1 associated RING domain 1 |
|
decreases expression |
ISO |
9 |
70,120,151 |
70,198,591 |
RGD:6480464 |
CTD |
| G |
Basp1 |
brain abundant, membrane attached signal protein 1 |
|
multiple interactions |
EXP |
2 |
76,877,616 |
76,927,721 |
RGD:6480464 |
CTD |
| G |
Bax |
Bcl2-associated X protein |
|
multiple interactions |
ISO |
1 |
95,933,023 |
95,938,176 |
RGD:6480464 |
CTD |
| G |
Bax |
Bcl2-associated X protein |
|
multiple interactions |
ISO |
1 |
95,933,023 |
95,938,176 |
RGD:6480464 |
CTD |
| G |
Bax |
Bcl2-associated X protein |
|
decreases expression |
ISO |
1 |
95,933,023 |
95,938,176 |
RGD:6480464 |
CTD |
| G |
Bax |
Bcl2-associated X protein |
|
decreases expression |
ISO |
1 |
95,933,023 |
95,938,176 |
RGD:6480464 |
CTD |
| G |
Bax |
Bcl2-associated X protein |
|
multiple interactions |
ISO |
1 |
95,933,023 |
95,938,176 |
RGD:6480464 |
CTD |
| G |
Bax |
Bcl2-associated X protein |
|
multiple interactions |
EXP |
1 |
95,933,023 |
95,938,176 |
RGD:6480464 |
CTD |
| G |
Bax |
Bcl2-associated X protein |
|
decreases expression |
ISO |
1 |
95,933,023 |
95,938,176 |
RGD:6480464 |
CTD |
| G |
Bax |
Bcl2-associated X protein |
|
increases expression |
EXP |
1 |
95,933,023 |
95,938,176 |
RGD:6480464 |
CTD |
| G |
Bax |
Bcl2-associated X protein |
|
multiple interactions |
EXP |
1 |
95,933,023 |
95,938,176 |
RGD:6480464 |
CTD |
| G |
Bcap29 |
B-cell receptor-associated protein 29 |
|
increases expression |
ISO |
6 |
49,464,362 |
49,504,424 |
RGD:6480464 |
CTD |
| G |
Bcap29 |
B-cell receptor-associated protein 29 |
|
multiple interactions |
ISO |
6 |
49,464,362 |
49,504,424 |
RGD:6480464 |
CTD |
| G |
Bcas1 |
breast carcinoma amplified sequence 1 |
|
multiple interactions |
ISO |
3 |
161,395,062 |
161,475,655 |
RGD:6480464 |
CTD |
| G |
Bcas1 |
breast carcinoma amplified sequence 1 |
|
increases expression |
ISO |
3 |
161,395,062 |
161,475,655 |
RGD:6480464 |
CTD |
| G |
Bche |
butyrylcholinesterase |
|
multiple interactions |
ISO |
2 |
164,329,613 |
164,427,994 |
RGD:6480464 |
CTD |
| G |
Bche |
butyrylcholinesterase |
|
decreases expression |
ISO |
2 |
164,329,613 |
164,427,994 |
RGD:6480464 |
CTD |
| G |
Bcl10 |
B-cell CLL/lymphoma 10 |
|
increases expression |
ISO |
2 |
244,116,880 |
244,126,393 |
RGD:6480464 |
CTD |
| G |
Bcl10 |
B-cell CLL/lymphoma 10 |
|
multiple interactions |
ISO |
2 |
244,116,880 |
244,126,393 |
RGD:6480464 |
CTD |
| G |
Bcl2 |
B-cell CLL/lymphoma 2 |
|
multiple interactions |
ISO |
13 |
12,730,736 |
12,905,108 |
RGD:6480464 |
CTD |
| G |
Bcl2 |
B-cell CLL/lymphoma 2 |
|
multiple interactions |
ISO |
13 |
12,730,736 |
12,905,108 |
RGD:6480464 |
CTD |
| G |
Bcl2 |
B-cell CLL/lymphoma 2 |
|
multiple interactions |
ISO |
13 |
12,730,736 |
12,905,108 |
RGD:6480464 |
CTD |
| G |
Bcl2 |
B-cell CLL/lymphoma 2 |
|
decreases expression |
ISO |
13 |
12,730,736 |
12,905,108 |
RGD:6480464 |
CTD |
| G |
Bcl2 |
B-cell CLL/lymphoma 2 |
|
decreases expression |
ISO |
13 |
12,730,736 |
12,905,108 |
RGD:6480464 |
CTD |
| G |
Bcl2 |
B-cell CLL/lymphoma 2 |
|
increases expression |
ISO |
13 |
12,730,736 |
12,905,108 |
RGD:6480464 |
CTD |
| G |
Bcl2 |
B-cell CLL/lymphoma 2 |
|
multiple interactions |
ISO |
13 |
12,730,736 |
12,905,108 |
RGD:6480464 |
CTD |
| G |
Bcl2 |
B-cell CLL/lymphoma 2 |
|
increases expression |
ISO |
13 |
12,730,736 |
12,905,108 |
RGD:6480464 |
CTD |
| G |
Bcl2 |
B-cell CLL/lymphoma 2 |
|
increases expression |
EXP |
13 |
12,730,736 |
12,905,108 |
RGD:6480464 |
CTD |
| G |
Bcl2 |
B-cell CLL/lymphoma 2 |
|
multiple interactions |
EXP |
13 |
12,730,736 |
12,905,108 |
RGD:6480464 |
CTD |
| G |
Bcl2 |
B-cell CLL/lymphoma 2 |
|
multiple interactions |
EXP |
13 |
12,730,736 |
12,905,108 |
RGD:6480464 |
CTD |
| G |
Bcl2l11 |
BCL2-like 11 (apoptosis facilitator) |
|
increases expression |
EXP |
3 |
115,692,323 |
115,722,701 |
RGD:6480464 |
CTD |
| G |
Bcl2l12 |
BCL2-like 12 (proline rich) |
|
multiple interactions |
ISO |
1 |
95,462,429 |
95,471,148 |
RGD:6480464 |
CTD |
| G |
Bcl2l12 |
BCL2-like 12 (proline rich) |
|
decreases expression |
ISO |
1 |
95,462,429 |
95,471,148 |
RGD:6480464 |
CTD |
| G |
Bcl3 |
B-cell CLL/lymphoma 3 |
|
multiple interactions |
EXP |
1 |
79,122,801 |
79,137,035 |
RGD:6480464 |
CTD |
| G |
Bcmo1 |
beta-carotene 15,15'-monooxygenase 1 |
|
multiple interactions |
ISO |
19 |
47,202,955 |
47,239,225 |
RGD:6480464 |
CTD |
| G |
Bcr |
breakpoint cluster region |
|
multiple interactions |
EXP |
20 |
13,972,773 |
14,097,816 |
RGD:6480464 |
CTD |
| G |
Bdkrb1 |
bradykinin receptor B1 |
|
multiple interactions |
ISO |
6 |
129,760,129 |
129,762,545 |
RGD:6480464 |
CTD |
| G |
Bdkrb1 |
bradykinin receptor B1 |
|
decreases expression |
ISO |
6 |
129,760,129 |
129,762,545 |
RGD:6480464 |
CTD |
| G |
Bhlhe41 |
basic helix-loop-helix family, member e41 |
|
multiple interactions |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Birc3 |
baculoviral IAP repeat-containing 3 |
|
increases expression |
ISO |
8 |
4,682,202 |
4,696,856 |
RGD:6480464 |
CTD |
| G |
Birc3 |
baculoviral IAP repeat-containing 3 |
|
multiple interactions |
ISO |
8 |
4,682,202 |
4,696,856 |
RGD:6480464 |
CTD |
| G |
Birc3 |
baculoviral IAP repeat-containing 3 |
|
multiple interactions |
EXP |
8 |
4,682,202 |
4,696,856 |
RGD:6480464 |
CTD |
| G |
Birc5 |
baculoviral IAP repeat-containing 5 |
|
multiple interactions |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Birc5 |
baculoviral IAP repeat-containing 5 |
|
multiple interactions |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Birc5 |
baculoviral IAP repeat-containing 5 |
|
multiple interactions |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Birc5 |
baculoviral IAP repeat-containing 5 |
|
increases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Birc5 |
baculoviral IAP repeat-containing 5 |
|
decreases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Birc5 |
baculoviral IAP repeat-containing 5 |
|
multiple interactions |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Birc5 |
baculoviral IAP repeat-containing 5 |
|
increases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Blm |
Bloom syndrome, RecQ helicase-like |
|
multiple interactions |
ISO |
1 |
136,271,573 |
136,358,077 |
RGD:6480464 |
CTD |
| G |
Blm |
Bloom syndrome, RecQ helicase-like |
|
decreases expression |
ISO |
1 |
136,271,573 |
136,358,077 |
RGD:6480464 |
CTD |
| G |
Bmp2 |
bone morphogenetic protein 2 |
|
decreases expression |
ISO |
3 |
121,372,692 |
121,381,236 |
RGD:6480464 |
CTD |
| G |
Bmp4 |
bone morphogenetic protein 4 |
|
affects expression |
ISO |
15 |
22,283,171 |
22,286,757 |
RGD:6480464 |
CTD |
| G |
Bmp4 |
bone morphogenetic protein 4 |
|
decreases expression |
ISO |
15 |
22,283,171 |
22,286,757 |
RGD:6480464 |
CTD |
| G |
Bmp7 |
bone morphogenetic protein 7 |
|
increases expression |
ISO |
3 |
163,723,429 |
163,799,567 |
RGD:6480464 |
CTD |
| G |
Bmpr1b |
bone morphogenetic protein receptor, type IB |
|
multiple interactions |
ISO |
2 |
239,727,569 |
239,767,802 |
RGD:6480464 |
CTD |
| G |
Bmpr1b |
bone morphogenetic protein receptor, type IB |
|
increases expression |
ISO |
2 |
239,727,569 |
239,767,802 |
RGD:6480464 |
CTD |
| G |
Brca1 |
breast cancer 1, early onset |
|
multiple interactions |
ISO |
10 |
90,513,630 |
90,572,676 |
RGD:6480464 |
CTD |
| G |
Brca1 |
breast cancer 1, early onset |
|
decreases expression |
ISO |
10 |
90,513,630 |
90,572,676 |
RGD:6480464 |
CTD |
| G |
Brca2 |
breast cancer 2, early onset |
|
multiple interactions |
ISO |
12 |
4,282,952 |
4,323,693 |
RGD:6480464 |
CTD |
| G |
Brca2 |
breast cancer 2, early onset |
|
decreases expression |
ISO |
12 |
4,282,952 |
4,323,693 |
RGD:6480464 |
CTD |
| G |
Brip1 |
BRCA1 interacting protein C-terminal helicase 1 |
|
decreases expression |
ISO |
10 |
74,313,004 |
74,436,532 |
RGD:6480464 |
CTD |
| G |
Brip1 |
BRCA1 interacting protein C-terminal helicase 1 |
|
multiple interactions |
ISO |
10 |
74,313,004 |
74,436,532 |
RGD:6480464 |
CTD |
| G |
Brix1 |
BRX1, biogenesis of ribosomes, homolog (S. cerevisiae) |
|
multiple interactions |
ISO |
2 |
59,826,894 |
59,837,772 |
RGD:6480464 |
CTD |
| G |
Brix1 |
BRX1, biogenesis of ribosomes, homolog (S. cerevisiae) |
|
decreases expression |
ISO |
2 |
59,826,894 |
59,837,772 |
RGD:6480464 |
CTD |
| G |
Bst1 |
bone marrow stromal cell antigen 1 |
|
increases expression |
ISO |
14 |
72,404,263 |
72,414,500 |
RGD:6480464 |
CTD |
| G |
Btg2 |
BTG family, member 2 |
|
multiple interactions |
ISO |
13 |
47,026,986 |
47,030,745 |
RGD:6480464 |
CTD |
| G |
Btg2 |
BTG family, member 2 |
|
decreases expression |
ISO |
13 |
47,026,986 |
47,030,745 |
RGD:6480464 |
CTD |
| G |
Bub1 |
BUB1 mitotic checkpoint serine/threonine kinase |
|
multiple interactions |
ISO |
3 |
115,323,510 |
115,354,906 |
RGD:6480464 |
CTD |
| G |
Bub1 |
BUB1 mitotic checkpoint serine/threonine kinase |
|
decreases expression |
ISO |
3 |
115,323,510 |
115,354,906 |
RGD:6480464 |
CTD |
| G |
Bub1b |
BUB1 mitotic checkpoint serine/threonine kinase B |
|
multiple interactions |
ISO |
3 |
105,063,018 |
105,116,145 |
RGD:6480464 |
CTD |
| G |
Bub1b |
BUB1 mitotic checkpoint serine/threonine kinase B |
|
decreases expression |
ISO |
3 |
105,063,018 |
105,116,145 |
RGD:6480464 |
CTD |
| G |
C1galt1 |
core 1 synthase, glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase, 1 |
|
decreases expression |
ISO |
4 |
32,903,434 |
32,933,953 |
RGD:6480464 |
CTD |
| G |
C4a |
complement component 4A (Rodgers blood group) |
|
multiple interactions |
EXP |
20 |
4,106,123 |
4,145,904 |
RGD:6480464 |
CTD |
| G |
C6 |
complement component 6 |
|
increases expression |
ISO |
2 |
53,691,290 |
53,764,539 |
RGD:6480464 |
CTD |
| G |
Cab39l |
calcium binding protein 39-like |
|
increases expression |
ISO |
15 |
38,552,234 |
38,640,594 |
RGD:6480464 |
CTD |
| G |
Cab39l |
calcium binding protein 39-like |
|
multiple interactions |
ISO |
15 |
38,552,234 |
38,640,594 |
RGD:6480464 |
CTD |
| G |
Cacnb1 |
calcium channel, voltage-dependent, beta 1 subunit |
|
decreases expression |
ISO |
10 |
86,764,283 |
86,784,791 |
RGD:6480464 |
CTD |
| G |
Cacng4 |
calcium channel, voltage-dependent, gamma subunit 4 |
|
multiple interactions |
ISO |
10 |
97,139,397 |
97,214,444 |
RGD:6480464 |
CTD |
| G |
Cacng4 |
calcium channel, voltage-dependent, gamma subunit 4 |
|
increases expression |
ISO |
10 |
97,139,397 |
97,214,444 |
RGD:6480464 |
CTD |
| G |
Cadps2 |
Ca++-dependent secretion activator 2 |
|
multiple interactions |
ISO |
4 |
49,658,535 |
50,206,014 |
RGD:6480464 |
CTD |
| G |
Cadps2 |
Ca++-dependent secretion activator 2 |
|
increases expression |
ISO |
4 |
49,658,535 |
50,206,014 |
RGD:6480464 |
CTD |
| G |
Calb1 |
calbindin 1 |
|
decreases expression |
ISO |
5 |
30,455,665 |
30,480,122 |
RGD:6480464 |
CTD |
| G |
Calr |
calreticulin |
|
affects expression |
ISO |
19 |
24,964,775 |
24,969,670 |
RGD:6480464 |
CTD |
| G |
Calr |
calreticulin |
|
multiple interactions |
ISO |
19 |
24,964,775 |
24,969,670 |
RGD:6480464 |
CTD |
| G |
Calr |
calreticulin |
|
increases expression |
ISO |
19 |
24,964,775 |
24,969,670 |
RGD:6480464 |
CTD |
| G |
Camk1d |
calcium/calmodulin-dependent protein kinase ID |
|
increases expression |
ISO |
17 |
83,649,720 |
84,061,160 |
RGD:6480464 |
CTD |
| G |
Camk1d |
calcium/calmodulin-dependent protein kinase ID |
|
multiple interactions |
ISO |
17 |
83,649,720 |
84,061,160 |
RGD:6480464 |
CTD |
| G |
Camk4 |
calcium/calmodulin-dependent protein kinase IV |
|
multiple interactions |
EXP |
18 |
25,404,123 |
25,625,785 |
RGD:6480464 |
CTD |
| G |
Camta1 |
calmodulin binding transcription activator 1 |
|
increases expression |
ISO |
5 |
168,201,249 |
169,046,038 |
RGD:6480464 |
CTD |
| G |
Capn12 |
calpain 12 |
|
multiple interactions |
ISO |
1 |
83,989,000 |
84,001,059 |
RGD:6480464 |
CTD |
| G |
Capn12 |
calpain 12 |
|
increases expression |
ISO |
1 |
83,989,000 |
84,001,059 |
RGD:6480464 |
CTD |
| G |
Capn2 |
calpain 2, (m/II) large subunit |
|
increases expression |
ISO |
13 |
98,473,367 |
98,524,463 |
RGD:6480464 |
CTD |
| G |
Capn2 |
calpain 2, (m/II) large subunit |
|
multiple interactions |
ISO |
13 |
98,473,367 |
98,524,463 |
RGD:6480464 |
CTD |
| G |
Capn2 |
calpain 2, (m/II) large subunit |
|
multiple interactions |
EXP |
13 |
98,473,367 |
98,524,463 |
RGD:6480464 |
CTD |
| G |
Car3 |
carbonic anhydrase 3 |
|
decreases expression |
ISO |
2 |
88,106,727 |
88,114,686 |
RGD:6480464 |
CTD |
| G |
Car4 |
carbonic anhydrase 4 |
|
multiple interactions |
EXP |
10 |
73,229,211 |
73,237,707 |
RGD:6480464 |
CTD |
| G |
Card6 |
caspase recruitment domain family, member 6 |
|
multiple interactions |
ISO |
2 |
54,282,217 |
54,293,630 |
RGD:6480464 |
CTD |
| G |
Card6 |
caspase recruitment domain family, member 6 |
|
increases expression |
ISO |
2 |
54,282,217 |
54,293,630 |
RGD:6480464 |
CTD |
| G |
Casc5 |
cancer susceptibility candidate 5 |
|
multiple interactions |
ISO |
3 |
105,561,365 |
105,615,047 |
RGD:6480464 |
CTD |
| G |
Casc5 |
cancer susceptibility candidate 5 |
|
decreases expression |
ISO |
3 |
105,561,365 |
105,615,047 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
decreases expression |
ISO |
16 |
48,944,226 |
48,962,420 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
multiple interactions |
ISO |
16 |
48,944,226 |
48,962,420 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
multiple interactions |
ISO |
16 |
48,944,226 |
48,962,420 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
decreases expression |
ISO |
16 |
48,944,226 |
48,962,420 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
multiple interactions |
EXP |
16 |
48,944,226 |
48,962,420 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
affects expression |
EXP |
16 |
48,944,226 |
48,962,420 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
multiple interactions |
EXP |
16 |
48,944,226 |
48,962,420 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
decreases expression |
EXP |
16 |
48,944,226 |
48,962,420 |
RGD:6480464 |
CTD |
| G |
Casp6 |
caspase 6 |
|
decreases expression |
EXP |
2 |
227,361,538 |
227,373,844 |
RGD:6480464 |
CTD |
| G |
Casp6 |
caspase 6 |
|
multiple interactions |
EXP |
2 |
227,361,538 |
227,373,844 |
RGD:6480464 |
CTD |
| G |
Casp8 |
caspase 8 |
|
multiple interactions |
EXP |
9 |
57,389,353 |
57,437,803 |
RGD:6480464 |
CTD |
| G |
Casp9 |
caspase 9, apoptosis-related cysteine peptidase |
|
decreases expression |
ISO |
5 |
160,704,234 |
160,721,796 |
RGD:6480464 |
CTD |
| G |
Casp9 |
caspase 9, apoptosis-related cysteine peptidase |
|
multiple interactions |
ISO |
5 |
160,704,234 |
160,721,796 |
RGD:6480464 |
CTD |
| G |
Casp9 |
caspase 9, apoptosis-related cysteine peptidase |
|
multiple interactions |
ISO |
5 |
160,704,234 |
160,721,796 |
RGD:6480464 |
CTD |
| G |
Casp9 |
caspase 9, apoptosis-related cysteine peptidase |
|
multiple interactions |
EXP |
5 |
160,704,234 |
160,721,796 |
RGD:6480464 |
CTD |
| G |
Casp9 |
caspase 9, apoptosis-related cysteine peptidase |
|
decreases expression |
ISO |
5 |
160,704,234 |
160,721,796 |
RGD:6480464 |
CTD |
| G |
Casr |
calcium-sensing receptor |
|
increases expression |
ISO |
11 |
66,084,169 |
66,153,292 |
RGD:6480464 |
CTD |
| G |
Casr |
calcium-sensing receptor |
|
multiple interactions |
ISO |
11 |
66,084,169 |
66,153,292 |
RGD:6480464 |
CTD |
| G |
Casr |
calcium-sensing receptor |
|
decreases expression |
ISO |
11 |
66,084,169 |
66,153,292 |
RGD:6480464 |
CTD |
| G |
Cat |
catalase |
|
multiple interactions |
ISO |
3 |
88,654,077 |
88,686,212 |
RGD:6480464 |
CTD |
| G |
Cbll1 |
Cbl proto-oncogene, E3 ubiquitin protein ligase-like 1 |
|
increases expression |
ISO |
6 |
49,352,961 |
49,366,947 |
RGD:6480464 |
CTD |
| G |
Cbll1 |
Cbl proto-oncogene, E3 ubiquitin protein ligase-like 1 |
|
multiple interactions |
ISO |
6 |
49,352,961 |
49,366,947 |
RGD:6480464 |
CTD |
| G |
Cbln2 |
cerebellin 2 precursor |
|
multiple interactions |
ISO |
18 |
83,306,945 |
83,313,398 |
RGD:6480464 |
CTD |
| G |
Cbln2 |
cerebellin 2 precursor |
|
decreases expression |
ISO |
18 |
83,306,945 |
83,313,398 |
RGD:6480464 |
CTD |
| G |
Cbx2 |
chromobox homolog 2 |
|
multiple interactions |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Cbx2 |
chromobox homolog 2 |
|
decreases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Ccdc111 |
coiled-coil domain containing 111 |
|
multiple interactions |
ISO |
16 |
48,968,598 |
48,997,032 |
RGD:6480464 |
CTD |
| G |
Ccdc111 |
coiled-coil domain containing 111 |
|
decreases expression |
ISO |
16 |
48,968,598 |
48,997,032 |
RGD:6480464 |
CTD |
| G |
Ccdc138 |
coiled-coil domain containing 138 |
|
multiple interactions |
ISO |
20 |
37,181,926 |
37,269,631 |
RGD:6480464 |
CTD |
| G |
Ccdc138 |
coiled-coil domain containing 138 |
|
decreases expression |
ISO |
20 |
37,181,926 |
37,269,631 |
RGD:6480464 |
CTD |
| G |
Ccdc14 |
coiled-coil domain containing 14 |
|
multiple interactions |
ISO |
11 |
67,872,420 |
67,905,568 |
RGD:6480464 |
CTD |
| G |
Ccdc14 |
coiled-coil domain containing 14 |
|
decreases expression |
ISO |
11 |
67,872,420 |
67,905,568 |
RGD:6480464 |
CTD |
| G |
Ccdc15 |
coiled-coil domain containing 15 |
|
multiple interactions |
ISO |
8 |
38,534,697 |
38,603,744 |
RGD:6480464 |
CTD |
| G |
Ccdc15 |
coiled-coil domain containing 15 |
|
decreases expression |
ISO |
8 |
38,534,697 |
38,603,744 |
RGD:6480464 |
CTD |
| G |
Ccdc18 |
coiled-coil domain containing 18 |
|
decreases expression |
ISO |
14 |
2,052,777 |
2,153,204 |
RGD:6480464 |
CTD |
| G |
Ccdc18 |
coiled-coil domain containing 18 |
|
multiple interactions |
ISO |
14 |
2,052,777 |
2,153,204 |
RGD:6480464 |
CTD |
| G |
Ccdc24 |
coiled-coil domain containing 24 |
|
multiple interactions |
ISO |
5 |
138,334,870 |
138,338,194 |
RGD:6480464 |
CTD |
| G |
Ccdc24 |
coiled-coil domain containing 24 |
|
increases expression |
ISO |
5 |
138,334,870 |
138,338,194 |
RGD:6480464 |
CTD |
| G |
Ccdc25 |
coiled-coil domain containing 25 |
|
decreases expression |
ISO |
15 |
45,259,453 |
45,292,156 |
RGD:6480464 |
CTD |
| G |
Ccdc34 |
coiled-coil domain containing 34 |
|
multiple interactions |
ISO |
3 |
95,475,133 |
95,510,284 |
RGD:6480464 |
CTD |
| G |
Ccdc34 |
coiled-coil domain containing 34 |
|
decreases expression |
ISO |
3 |
95,475,133 |
95,510,284 |
RGD:6480464 |
CTD |
| G |
Ccdc50 |
coiled-coil domain containing 50 |
|
decreases expression |
ISO |
11 |
75,302,647 |
75,360,549 |
RGD:6480464 |
CTD |
| G |
Ccdc64 |
coiled-coil domain containing 64 |
|
multiple interactions |
ISO |
12 |
42,139,165 |
42,227,651 |
RGD:6480464 |
CTD |
| G |
Ccdc64 |
coiled-coil domain containing 64 |
|
increases expression |
ISO |
12 |
42,139,165 |
42,227,651 |
RGD:6480464 |
CTD |
| G |
Ccnd1 |
cyclin D1 |
|
multiple interactions |
EXP |
1 |
205,357,235 |
205,366,757 |
RGD:6480464 |
CTD |
| G |
Ccne2 |
cyclin E2 |
|
decreases expression |
ISO |
5 |
25,032,748 |
25,044,509 |
RGD:6480464 |
CTD |
| G |
Ccnf |
cyclin F |
|
multiple interactions |
ISO |
10 |
13,474,659 |
13,500,979 |
RGD:6480464 |
CTD |
| G |
Ccnf |
cyclin F |
|
decreases expression |
ISO |
10 |
13,474,659 |
13,500,979 |
RGD:6480464 |
CTD |
| G |
Ccng1 |
cyclin G1 |
|
multiple interactions |
EXP |
10 |
25,776,380 |
25,782,754 |
RGD:6480464 |
CTD |
| G |
Ccsap |
centriole, cilia and spindle-associated protein |
|
multiple interactions |
ISO |
19 |
54,023,536 |
54,039,295 |
RGD:6480464 |
CTD |
| G |
Ccsap |
centriole, cilia and spindle-associated protein |
|
decreases expression |
ISO |
19 |
54,023,536 |
54,039,295 |
RGD:6480464 |
CTD |
| G |
Cd14 |
CD14 molecule |
|
multiple interactions |
ISO |
18 |
29,374,593 |
29,376,190 |
RGD:6480464 |
CTD |
| G |
Cd14 |
CD14 molecule |
|
increases expression |
ISO |
18 |
29,374,593 |
29,376,190 |
RGD:6480464 |
CTD |
| G |
Cd200 |
Cd200 molecule |
|
affects expression |
ISO |
11 |
56,946,504 |
56,974,256 |
RGD:6480464 |
CTD |
| G |
Cd24 |
CD24 molecule |
|
multiple interactions |
ISO |
20 |
47,502,354 |
47,507,663 |
RGD:6480464 |
CTD |
| G |
Cd24 |
CD24 molecule |
|
multiple interactions |
EXP |
20 |
47,502,354 |
47,507,663 |
RGD:6480464 |
CTD |
| G |
Cd24 |
CD24 molecule |
|
increases expression |
ISO |
20 |
47,502,354 |
47,507,663 |
RGD:6480464 |
CTD |
| G |
Cd274 |
CD274 molecule |
|
multiple interactions |
ISO |
1 |
233,053,607 |
233,065,384 |
RGD:6480464 |
CTD |
| G |
Cd274 |
CD274 molecule |
|
decreases expression |
ISO |
1 |
233,053,607 |
233,065,384 |
RGD:6480464 |
CTD |
| G |
Cd36 |
CD36 molecule (thrombospondin receptor) |
|
multiple interactions |
EXP |
4 |
13,471,878 |
13,525,620 |
RGD:6480464 |
CTD |
| G |
Cd38 |
CD38 molecule |
|
affects abundance |
ISO |
14 |
72,320,479 |
72,360,329 |
RGD:6480464 |
CTD |
| G |
Cd59 |
CD59 molecule, complement regulatory protein |
|
multiple interactions |
ISO |
3 |
89,243,600 |
89,245,129 |
RGD:6480464 |
CTD |
| G |
Cd59 |
CD59 molecule, complement regulatory protein |
|
increases expression |
ISO |
3 |
89,243,600 |
89,245,129 |
RGD:6480464 |
CTD |
| G |
Cd63 |
Cd63 molecule |
|
increases expression |
ISO |
7 |
2,208,659 |
2,211,323 |
RGD:6480464 |
CTD |
| G |
Cd68 |
Cd68 molecule |
|
increases expression |
ISO |
10 |
56,481,701 |
56,483,580 |
RGD:6480464 |
CTD |
| G |
Cd68 |
Cd68 molecule |
|
multiple interactions |
ISO |
10 |
56,481,701 |
56,483,580 |
RGD:6480464 |
CTD |
| G |
Cd7 |
Cd7 molecule |
|
multiple interactions |
ISO |
10 |
110,250,174 |
110,253,055 |
RGD:6480464 |
CTD |
| G |
Cd7 |
Cd7 molecule |
|
increases expression |
ISO |
10 |
110,250,174 |
110,253,055 |
RGD:6480464 |
CTD |
| G |
Cd82 |
Cd82 molecule |
|
multiple interactions |
ISO |
3 |
77,831,771 |
77,875,764 |
RGD:6480464 |
CTD |
| G |
Cd82 |
Cd82 molecule |
|
increases expression |
ISO |
3 |
77,831,771 |
77,875,764 |
RGD:6480464 |
CTD |
| G |
Cdc20 |
cell division cycle 20 |
|
multiple interactions |
ISO |
5 |
138,913,180 |
138,916,744 |
RGD:6480464 |
CTD |
| G |
Cdc20 |
cell division cycle 20 |
|
decreases expression |
ISO |
5 |
138,913,180 |
138,916,744 |
RGD:6480464 |
CTD |
| G |
Cdc25b |
cell division cycle 25B |
|
multiple interactions |
ISO |
3 |
118,893,716 |
118,903,516 |
RGD:6480464 |
CTD |
| G |
Cdc25b |
cell division cycle 25B |
|
decreases expression |
ISO |
3 |
118,893,716 |
118,903,516 |
RGD:6480464 |
CTD |
| G |
Cdc25c |
cell division cycle 25C |
|
multiple interactions |
ISO |
18 |
27,206,537 |
27,225,811 |
RGD:6480464 |
CTD |
| G |
Cdc25c |
cell division cycle 25C |
|
decreases expression |
ISO |
18 |
27,206,537 |
27,225,811 |
RGD:6480464 |
CTD |
| G |
Cdc42ep3 |
CDC42 effector protein (Rho GTPase binding) 3 |
|
multiple interactions |
ISO |
6 |
2,111,458 |
2,132,242 |
RGD:6480464 |
CTD |
| G |
Cdc42ep3 |
CDC42 effector protein (Rho GTPase binding) 3 |
|
increases expression |
ISO |
6 |
2,111,458 |
2,132,242 |
RGD:6480464 |
CTD |
| G |
Cdc6 |
cell division cycle 6 |
|
multiple interactions |
ISO |
10 |
87,684,493 |
87,697,865 |
RGD:6480464 |
CTD |
| G |
Cdc6 |
cell division cycle 6 |
|
decreases expression |
ISO |
10 |
87,684,493 |
87,697,865 |
RGD:6480464 |
CTD |
| G |
Cdca2 |
cell division cycle associated 2 |
|
multiple interactions |
ISO |
15 |
47,225,711 |
47,271,412 |
RGD:6480464 |
CTD |
| G |
Cdca2 |
cell division cycle associated 2 |
|
decreases expression |
ISO |
15 |
47,225,711 |
47,271,412 |
RGD:6480464 |
CTD |
| G |
Cdca3 |
cell division cycle associated 3 |
|
multiple interactions |
ISO |
4 |
160,952,986 |
160,956,574 |
RGD:6480464 |
CTD |
| G |
Cdca3 |
cell division cycle associated 3 |
|
decreases expression |
ISO |
4 |
160,952,986 |
160,956,574 |
RGD:6480464 |
CTD |
| G |
Cdca4 |
cell division cycle associated 4 |
|
multiple interactions |
ISO |
6 |
137,818,816 |
137,828,119 |
RGD:6480464 |
CTD |
| G |
Cdca4 |
cell division cycle associated 4 |
|
decreases expression |
ISO |
6 |
137,818,816 |
137,828,119 |
RGD:6480464 |
CTD |
| G |
Cdca5 |
cell division cycle associated 5 |
|
multiple interactions |
ISO |
1 |
210,247,351 |
210,247,881 |
RGD:6480464 |
CTD |
| G |
Cdca5 |
cell division cycle associated 5 |
|
decreases expression |
ISO |
1 |
210,247,351 |
210,247,881 |
RGD:6480464 |
CTD |
| G |
Cdca7 |
cell division cycle associated 7 |
|
decreases expression |
ISO |
3 |
54,948,493 |
54,959,128 |
RGD:6480464 |
CTD |
| G |
Cdca7 |
cell division cycle associated 7 |
|
multiple interactions |
ISO |
3 |
54,948,493 |
54,959,128 |
RGD:6480464 |
CTD |
| G |
Cdca7 |
cell division cycle associated 7 |
|
multiple interactions |
EXP |
3 |
54,948,493 |
54,959,128 |
RGD:6480464 |
CTD |
| G |
Cdca7l |
cell division cycle associated 7 like |
|
multiple interactions |
ISO |
6 |
145,146,073 |
145,191,663 |
RGD:6480464 |
CTD |
| G |
Cdca7l |
cell division cycle associated 7 like |
|
decreases expression |
ISO |
6 |
145,146,073 |
145,191,663 |
RGD:6480464 |
CTD |
| G |
Cdca8 |
cell division cycle associated 8 |
|
multiple interactions |
ISO |
5 |
144,251,164 |
144,276,352 |
RGD:6480464 |
CTD |
| G |
Cdca8 |
cell division cycle associated 8 |
|
decreases expression |
ISO |
5 |
144,251,164 |
144,276,352 |
RGD:6480464 |
CTD |
| G |
Cdh13 |
cadherin 13 |
|
multiple interactions |
EXP |
19 |
48,507,173 |
49,575,123 |
RGD:6480464 |
CTD |
| G |
Cdipt |
CDP-diacylglycerol--inositol 3-phosphatidyltransferase |
|
affects expression |
ISO |
1 |
186,153,278 |
186,157,415 |
RGD:6480464 |
CTD |
| G |
Cdk19 |
cyclin-dependent kinase 19 |
|
increases expression |
ISO |
20 |
44,527,463 |
44,670,028 |
RGD:6480464 |
CTD |
| G |
Cdk2 |
cyclin dependent kinase 2 |
|
multiple interactions |
ISO |
7 |
2,000,196 |
2,007,682 |
RGD:6480464 |
CTD |
| G |
Cdk2 |
cyclin dependent kinase 2 |
|
decreases expression |
ISO |
7 |
2,000,196 |
2,007,682 |
RGD:6480464 |
CTD |
| G |
Cdkn1a |
cyclin-dependent kinase inhibitor 1A |
|
decreases expression |
ISO |
20 |
7,376,325 |
7,386,778 |
RGD:6480464 |
CTD |
| G |
Cdkn1a |
cyclin-dependent kinase inhibitor 1A |
|
increases expression |
ISO |
20 |
7,376,325 |
7,386,778 |
RGD:6480464 |
CTD |
| G |
Cdkn1a |
cyclin-dependent kinase inhibitor 1A |
|
multiple interactions |
EXP |
20 |
7,376,325 |
7,386,778 |
RGD:6480464 |
CTD |
| G |
Cdkn1b |
cyclin-dependent kinase inhibitor 1B |
|
decreases expression |
ISO |
4 |
171,841,705 |
171,846,506 |
RGD:6480464 |
CTD |
| G |
Cdkn1c |
cyclin-dependent kinase inhibitor 1C |
|
decreases expression |
ISO |
1 |
203,835,215 |
203,837,844 |
RGD:6480464 |
CTD |
| G |
Cdkn2aipnl |
CDKN2A interacting protein N-terminal like |
|
increases expression |
ISO |
10 |
37,492,021 |
37,501,456 |
RGD:6480464 |
CTD |
| G |
Cdkn2b |
cyclin-dependent kinase inhibitor 2B (p15, inhibits CDK4) |
|
multiple interactions |
ISO |
5 |
108,939,669 |
108,945,293 |
RGD:6480464 |
CTD |
| G |
Cdkn2b |
cyclin-dependent kinase inhibitor 2B (p15, inhibits CDK4) |
|
increases expression |
ISO |
5 |
108,939,669 |
108,945,293 |
RGD:6480464 |
CTD |
| G |
Cdkn2c |
cyclin-dependent kinase inhibitor 2C (p18, inhibits CDK4) |
|
decreases expression |
ISO |
5 |
131,012,524 |
131,017,679 |
RGD:6480464 |
CTD |
| G |
Cdkn2c |
cyclin-dependent kinase inhibitor 2C (p18, inhibits CDK4) |
|
multiple interactions |
ISO |
5 |
131,012,524 |
131,017,679 |
RGD:6480464 |
CTD |
| G |
Cdkn3 |
cyclin-dependent kinase inhibitor 3 |
|
decreases expression |
ISO |
15 |
22,617,409 |
22,624,922 |
RGD:6480464 |
CTD |
| G |
Cdkn3 |
cyclin-dependent kinase inhibitor 3 |
|
multiple interactions |
ISO |
15 |
22,617,409 |
22,624,922 |
RGD:6480464 |
CTD |
| G |
Cdkn3 |
cyclin-dependent kinase inhibitor 3 |
|
multiple interactions |
EXP |
15 |
22,617,409 |
22,624,922 |
RGD:6480464 |
CTD |
| G |
Cdrt4 |
CMT1A duplicated region transcript 4 |
|
multiple interactions |
ISO |
10 |
49,164,392 |
49,166,416 |
RGD:6480464 |
CTD |
| G |
Cdrt4 |
CMT1A duplicated region transcript 4 |
|
increases expression |
ISO |
10 |
49,164,392 |
49,166,416 |
RGD:6480464 |
CTD |
| G |
Cdt1 |
chromatin licensing and DNA replication factor 1 |
|
multiple interactions |
ISO |
19 |
52,848,559 |
52,853,880 |
RGD:6480464 |
CTD |
| G |
Cdt1 |
chromatin licensing and DNA replication factor 1 |
|
decreases expression |
ISO |
19 |
52,848,559 |
52,853,880 |
RGD:6480464 |
CTD |
| G |
Ceacam1 |
carcinoembryonic antigen-related cell adhesion molecule 1 (biliary glycoprotein) |
|
decreases expression |
ISO |
1 |
80,742,540 |
80,758,943 |
RGD:6480464 |
CTD |
| G |
Cebpa |
CCAAT/enhancer binding protein (C/EBP), alpha |
|
decreases expression |
ISO |
1 |
87,626,111 |
87,627,499 |
RGD:6480464 |
CTD |
| G |
Cebpb |
CCAAT/enhancer binding protein (C/EBP), beta |
|
multiple interactions |
EXP |
3 |
158,826,021 |
158,827,848 |
RGD:6480464 |
CTD |
| G |
Cebpd |
CCAAT/enhancer binding protein (C/EBP), delta |
|
multiple interactions |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Cebpd |
CCAAT/enhancer binding protein (C/EBP), delta |
|
decreases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Cebpd |
CCAAT/enhancer binding protein (C/EBP), delta |
|
multiple interactions |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Cecr6 |
cat eye syndrome chromosome region, candidate 6 |
|
multiple interactions |
ISO |
4 |
156,870,363 |
156,872,081 |
RGD:6480464 |
CTD |
| G |
Cecr6 |
cat eye syndrome chromosome region, candidate 6 |
|
increases expression |
ISO |
4 |
156,870,363 |
156,872,081 |
RGD:6480464 |
CTD |
| G |
Cel |
carboxyl ester lipase |
|
multiple interactions |
ISO |
3 |
7,541,127 |
7,549,245 |
RGD:6480464 |
CTD |
| G |
Cel |
carboxyl ester lipase |
|
decreases expression |
ISO |
3 |
7,541,127 |
7,549,245 |
RGD:6480464 |
CTD |
| G |
Cenpa |
centromere protein A |
|
multiple interactions |
ISO |
6 |
25,686,603 |
25,693,840 |
RGD:6480464 |
CTD |
| G |
Cenpa |
centromere protein A |
|
decreases expression |
ISO |
6 |
25,686,603 |
25,693,840 |
RGD:6480464 |
CTD |
| G |
Cenpe |
centromere protein E |
|
multiple interactions |
ISO |
2 |
232,699,627 |
232,758,329 |
RGD:6480464 |
CTD |
| G |
Cenpe |
centromere protein E |
|
decreases expression |
ISO |
2 |
232,699,627 |
232,758,329 |
RGD:6480464 |
CTD |
| G |
Cenpf |
centromere protein F |
|
multiple interactions |
ISO |
13 |
105,920,242 |
105,965,655 |
RGD:6480464 |
CTD |
| G |
Cenpf |
centromere protein F |
|
decreases expression |
ISO |
13 |
105,920,242 |
105,965,655 |
RGD:6480464 |
CTD |
| G |
Cenph |
centromere protein H |
|
multiple interactions |
ISO |
2 |
31,556,870 |
31,570,470 |
RGD:6480464 |
CTD |
| G |
Cenph |
centromere protein H |
|
decreases expression |
ISO |
2 |
31,556,870 |
31,570,470 |
RGD:6480464 |
CTD |
| G |
Cenpi |
centromere protein I |
|
decreases expression |
ISO |
X |
121,786,667 |
121,837,546 |
RGD:6480464 |
CTD |
| G |
Cenpi |
centromere protein I |
|
multiple interactions |
ISO |
X |
121,786,667 |
121,837,546 |
RGD:6480464 |
CTD |
| G |
Cenpj |
centromere protein J |
|
decreases expression |
ISO |
15 |
35,487,198 |
35,550,034 |
RGD:6480464 |
CTD |
| G |
Cenpj |
centromere protein J |
|
multiple interactions |
ISO |
15 |
35,487,198 |
35,550,034 |
RGD:6480464 |
CTD |
| G |
Cenpk |
centromere protein K |
|
multiple interactions |
ISO |
2 |
35,159,157 |
35,182,167 |
RGD:6480464 |
CTD |
| G |
Cenpk |
centromere protein K |
|
decreases expression |
ISO |
2 |
35,159,157 |
35,182,167 |
RGD:6480464 |
CTD |
| G |
Cenpl |
centromere protein L |
|
multiple interactions |
ISO |
13 |
76,629,572 |
76,644,429 |
RGD:6480464 |
CTD |
| G |
Cenpl |
centromere protein L |
|
decreases expression |
ISO |
13 |
76,629,572 |
76,644,429 |
RGD:6480464 |
CTD |
| G |
Cenpm |
centromere protein M |
|
multiple interactions |
ISO |
7 |
120,607,395 |
120,619,299 |
RGD:6480464 |
CTD |
| G |
Cenpm |
centromere protein M |
|
decreases expression |
ISO |
7 |
120,607,395 |
120,619,299 |
RGD:6480464 |
CTD |
| G |
Cenpq |
centromere protein Q |
|
decreases expression |
ISO |
9 |
15,758,645 |
15,768,747 |
RGD:6480464 |
CTD |
| G |
Cenpq |
centromere protein Q |
|
multiple interactions |
ISO |
9 |
15,758,645 |
15,768,747 |
RGD:6480464 |
CTD |
| G |
Cenpw |
centromere protein W |
|
multiple interactions |
ISO |
1 |
28,268,281 |
28,273,220 |
RGD:6480464 |
CTD |
| G |
Cenpw |
centromere protein W |
|
decreases expression |
ISO |
1 |
28,268,281 |
28,273,220 |
RGD:6480464 |
CTD |
| G |
Cep152 |
centrosomal protein 152 |
|
decreases expression |
ISO |
3 |
112,864,055 |
112,929,038 |
RGD:6480464 |
CTD |
| G |
Cep152 |
centrosomal protein 152 |
|
multiple interactions |
ISO |
3 |
112,864,055 |
112,929,038 |
RGD:6480464 |
CTD |
| G |
Cep350 |
centrosomal protein 350 |
|
multiple interactions |
ISO |
13 |
70,817,148 |
70,994,172 |
RGD:6480464 |
CTD |
| G |
Cep350 |
centrosomal protein 350 |
|
increases expression |
ISO |
13 |
70,817,148 |
70,994,172 |
RGD:6480464 |
CTD |
| G |
Cep55 |
centrosomal protein 55 |
|
multiple interactions |
ISO |
1 |
242,382,809 |
242,398,281 |
RGD:6480464 |
CTD |
| G |
Cep55 |
centrosomal protein 55 |
|
decreases expression |
ISO |
1 |
242,382,809 |
242,398,281 |
RGD:6480464 |
CTD |
| G |
Cep57l1 |
centrosomal protein 57-like 1 |
|
multiple interactions |
ISO |
20 |
45,730,365 |
45,785,949 |
RGD:6480464 |
CTD |
| G |
Cep57l1 |
centrosomal protein 57-like 1 |
|
decreases expression |
ISO |
20 |
45,730,365 |
45,785,949 |
RGD:6480464 |
CTD |
| G |
Cep63 |
centrosomal protein 63 |
|
multiple interactions |
ISO |
8 |
107,548,503 |
107,600,193 |
RGD:6480464 |
CTD |
| G |
Cep63 |
centrosomal protein 63 |
|
decreases expression |
ISO |
8 |
107,548,503 |
107,600,193 |
RGD:6480464 |
CTD |
| G |
Cep72 |
centrosomal protein 72 |
|
multiple interactions |
ISO |
1 |
30,031,815 |
30,061,725 |
RGD:6480464 |
CTD |
| G |
Cep78 |
centrosomal protein 78 |
|
multiple interactions |
ISO |
1 |
219,319,422 |
219,348,011 |
RGD:6480464 |
CTD |
| G |
Chaf1b |
chromatin assembly factor 1, subunit B (p60) |
|
decreases expression |
ISO |
11 |
34,110,848 |
34,130,928 |
RGD:6480464 |
CTD |
| G |
Chek2 |
checkpoint kinase 2 |
|
decreases expression |
ISO |
12 |
45,933,900 |
45,965,427 |
RGD:6480464 |
CTD |
| G |
Chpf |
chondroitin polymerizing factor |
|
multiple interactions |
ISO |
9 |
74,749,945 |
74,754,639 |
RGD:6480464 |
CTD |
| G |
Chpf |
chondroitin polymerizing factor |
|
increases expression |
ISO |
9 |
74,749,945 |
74,754,639 |
RGD:6480464 |
CTD |
| G |
Chpt1 |
choline phosphotransferase 1 |
|
increases expression |
ISO |
7 |
25,171,417 |
25,198,384 |
RGD:6480464 |
CTD |
| G |
Chrd |
chordin |
|
increases expression |
ISO |
11 |
82,401,701 |
82,410,401 |
RGD:6480464 |
CTD |
| G |
Chrm3 |
cholinergic receptor, muscarinic 3 |
|
increases expression |
ISO |
17 |
71,214,906 |
71,218,463 |
RGD:6480464 |
CTD |
| G |
Chrm3 |
cholinergic receptor, muscarinic 3 |
|
multiple interactions |
ISO |
17 |
71,214,906 |
71,218,463 |
RGD:6480464 |
CTD |
| G |
Chrna2 |
cholinergic receptor, nicotinic, alpha 2 (neuronal) |
|
multiple interactions |
ISO |
15 |
45,570,809 |
45,587,091 |
RGD:6480464 |
CTD |
| G |
Chrna2 |
cholinergic receptor, nicotinic, alpha 2 (neuronal) |
|
increases expression |
ISO |
15 |
45,570,809 |
45,587,091 |
RGD:6480464 |
CTD |
| G |
Chrnd |
cholinergic receptor, nicotinic, delta (muscle) |
|
multiple interactions |
EXP |
9 |
85,996,421 |
86,004,839 |
RGD:6480464 |
CTD |
| G |
Chrne |
cholinergic receptor, nicotinic, epsilon (muscle) |
|
multiple interactions |
ISO |
10 |
57,497,192 |
57,501,511 |
RGD:6480464 |
CTD |
| G |
Chrne |
cholinergic receptor, nicotinic, epsilon (muscle) |
|
increases expression |
ISO |
10 |
57,497,192 |
57,501,511 |
RGD:6480464 |
CTD |
| G |
Chtf18 |
CTF18, chromosome transmission fidelity factor 18 homolog (S. cerevisiae) |
|
multiple interactions |
ISO |
10 |
14,988,146 |
14,996,182 |
RGD:6480464 |
CTD |
| G |
Chtf18 |
CTF18, chromosome transmission fidelity factor 18 homolog (S. cerevisiae) |
|
decreases expression |
ISO |
10 |
14,988,146 |
14,996,182 |
RGD:6480464 |
CTD |
| G |
Chuk |
conserved helix-loop-helix ubiquitous kinase |
|
affects expression |
ISO |
1 |
249,122,845 |
249,158,369 |
RGD:6480464 |
CTD |
| G |
Cib2 |
calcium and integrin binding family member 2 |
|
multiple interactions |
EXP |
8 |
58,093,941 |
58,110,808 |
RGD:6480464 |
CTD |
| G |
Cidea |
cell death-inducing DFFA-like effector a |
|
multiple interactions |
EXP |
18 |
63,871,538 |
63,896,975 |
RGD:6480464 |
CTD |
| G |
Cish |
cytokine inducible SH2-containing protein |
|
decreases expression |
ISO |
8 |
112,541,034 |
112,545,982 |
RGD:6480464 |
CTD |
| G |
Cish |
cytokine inducible SH2-containing protein |
|
increases expression |
ISO |
8 |
112,541,034 |
112,545,982 |
RGD:6480464 |
CTD |
| G |
Cit |
citron (rho-interacting, serine/threonine kinase 21) |
|
multiple interactions |
ISO |
12 |
41,858,134 |
42,019,601 |
RGD:6480464 |
CTD |
| G |
Cit |
citron (rho-interacting, serine/threonine kinase 21) |
|
decreases expression |
ISO |
12 |
41,858,134 |
42,019,601 |
RGD:6480464 |
CTD |
| G |
Ckap2 |
cytoskeleton associated protein 2 |
|
multiple interactions |
ISO |
16 |
74,492,221 |
74,518,743 |
RGD:6480464 |
CTD |
| G |
Ckap2 |
cytoskeleton associated protein 2 |
|
decreases expression |
ISO |
16 |
74,492,221 |
74,518,743 |
RGD:6480464 |
CTD |
| G |
Ckap2l |
cytoskeleton associated protein 2-like |
|
multiple interactions |
ISO |
3 |
116,885,189 |
116,911,173 |
RGD:6480464 |
CTD |
| G |
Ckap2l |
cytoskeleton associated protein 2-like |
|
decreases expression |
ISO |
3 |
116,885,189 |
116,911,173 |
RGD:6480464 |
CTD |
| G |
Cklf |
chemokine-like factor |
|
multiple interactions |
ISO |
19 |
655,880 |
665,215 |
RGD:6480464 |
CTD |
| G |
Cklf |
chemokine-like factor |
|
decreases expression |
ISO |
19 |
655,880 |
665,215 |
RGD:6480464 |
CTD |
| G |
Cklf |
chemokine-like factor |
|
decreases expression |
ISO |
19 |
655,880 |
665,215 |
RGD:6480464 |
CTD |
| G |
Cks1b |
CDC28 protein kinase regulatory subunit 1B |
|
multiple interactions |
ISO |
2 |
181,611,639 |
181,616,222 |
RGD:6480464 |
CTD |
| G |
Cks1b |
CDC28 protein kinase regulatory subunit 1B |
|
decreases expression |
ISO |
2 |
181,611,639 |
181,616,222 |
RGD:6480464 |
CTD |
| G |
Cks2 |
CDC28 protein kinase regulatory subunit 2 |
|
decreases expression |
ISO |
17 |
19,423,502 |
19,429,451 |
RGD:6480464 |
CTD |
| G |
Cks2 |
CDC28 protein kinase regulatory subunit 2 |
|
multiple interactions |
ISO |
17 |
19,423,502 |
19,429,451 |
RGD:6480464 |
CTD |
| G |
Clcn1 |
chloride channel, voltage-sensitive 1 |
|
multiple interactions |
ISO |
4 |
70,052,319 |
70,081,449 |
RGD:6480464 |
CTD |
| G |
Clcn1 |
chloride channel, voltage-sensitive 1 |
|
decreases expression |
ISO |
4 |
70,052,319 |
70,081,449 |
RGD:6480464 |
CTD |
| G |
Clcn4 |
chloride channel, voltage-sensitive 4 |
|
affects expression |
ISO |
X |
44,355,648 |
44,419,524 |
RGD:6480464 |
CTD |
| G |
Cldn12 |
claudin 12 |
|
multiple interactions |
ISO |
4 |
25,213,105 |
25,219,260 |
RGD:6480464 |
CTD |
| G |
Cldn12 |
claudin 12 |
|
increases expression |
ISO |
4 |
25,213,105 |
25,219,260 |
RGD:6480464 |
CTD |
| G |
Cldn4 |
claudin 4 |
|
decreases expression |
ISO |
12 |
22,816,134 |
22,817,932 |
RGD:6480464 |
CTD |
| G |
Cldn4 |
claudin 4 |
|
affects expression |
ISO |
12 |
22,816,134 |
22,817,932 |
RGD:6480464 |
CTD |
| G |
Cldn5 |
claudin 5 |
|
affects expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Cldn8 |
claudin 8 |
|
decreases expression |
ISO |
11 |
28,419,612 |
28,421,861 |
RGD:6480464 |
CTD |
| G |
Cldn8 |
claudin 8 |
|
multiple interactions |
ISO |
11 |
28,419,612 |
28,421,861 |
RGD:6480464 |
CTD |
| G |
Cldn8 |
claudin 8 |
|
increases expression |
ISO |
11 |
28,419,612 |
28,421,861 |
RGD:6480464 |
CTD |
| G |
Cldn8 |
claudin 8 |
|
affects expression |
ISO |
11 |
28,419,612 |
28,421,861 |
RGD:6480464 |
CTD |
| G |
Clec2h |
C-type lectin domain family 2, member H |
|
decreases expression |
ISO |
4 |
166,193,710 |
166,299,866 |
RGD:6480464 |
CTD |
| G |
Clip4 |
CAP-GLY domain containing linker protein family, member 4 |
|
multiple interactions |
ISO |
6 |
23,749,168 |
23,832,427 |
RGD:6480464 |
CTD |
| G |
Clip4 |
CAP-GLY domain containing linker protein family, member 4 |
|
increases expression |
ISO |
6 |
23,749,168 |
23,832,427 |
RGD:6480464 |
CTD |
| G |
Cln6 |
ceroid-lipofuscinosis, neuronal 6, late infantile, variant |
|
multiple interactions |
EXP |
8 |
66,987,057 |
67,002,013 |
RGD:6480464 |
CTD |
| G |
Clspn |
claspin |
|
multiple interactions |
ISO |
5 |
145,930,764 |
145,965,672 |
RGD:6480464 |
CTD |
| G |
Clspn |
claspin |
|
decreases expression |
ISO |
5 |
145,930,764 |
145,965,672 |
RGD:6480464 |
CTD |
| G |
Clu |
clusterin |
|
multiple interactions |
EXP |
15 |
45,365,779 |
45,405,314 |
RGD:6480464 |
CTD |
| G |
Clu |
clusterin |
|
multiple interactions |
EXP |
15 |
45,365,779 |
45,405,314 |
RGD:6480464 |
CTD |
| G |
Cmbl |
carboxymethylenebutenolidase homolog (Pseudomonas) |
|
increases expression |
ISO |
2 |
83,659,292 |
83,681,042 |
RGD:6480464 |
CTD |
| G |
Cml5 |
camello-like 5 |
|
increases expression |
ISO |
4 |
119,981,266 |
120,006,794 |
RGD:6480464 |
CTD |
| G |
Cmss1 |
cms1 ribosomal small subunit homolog (yeast) |
|
multiple interactions |
ISO |
11 |
43,763,988 |
44,068,609 |
RGD:6480464 |
CTD |
| G |
Cmss1 |
cms1 ribosomal small subunit homolog (yeast) |
|
decreases expression |
ISO |
11 |
43,763,988 |
44,068,609 |
RGD:6480464 |
CTD |
| G |
Cnih2 |
cornichon homolog 2 (Drosophila) |
|
multiple interactions |
ISO |
1 |
207,715,692 |
207,717,588 |
RGD:6480464 |
CTD |
| G |
Cnih2 |
cornichon homolog 2 (Drosophila) |
|
decreases expression |
ISO |
1 |
207,715,692 |
207,717,588 |
RGD:6480464 |
CTD |
| G |
Cnksr1 |
connector enhancer of kinase suppressor of Ras 1 |
|
increases expression |
ISO |
5 |
152,972,551 |
152,983,208 |
RGD:6480464 |
CTD |
| G |
Cnksr1 |
connector enhancer of kinase suppressor of Ras 1 |
|
multiple interactions |
EXP |
5 |
152,972,551 |
152,983,208 |
RGD:6480464 |
CTD |
| G |
Cntn1 |
contactin 1 |
|
multiple interactions |
EXP |
7 |
130,658,836 |
130,845,071 |
RGD:6480464 |
CTD |
| G |
Cntnap2 |
contactin associated protein-like 2 |
|
decreases expression |
ISO |
4 |
74,277,978 |
75,440,178 |
RGD:6480464 |
CTD |
| G |
Col15a1 |
collagen, type XV, alpha 1 |
|
multiple interactions |
EXP |
5 |
63,825,907 |
63,930,633 |
RGD:6480464 |
CTD |
| G |
Col18a1 |
collagen, type XVIII, alpha 1 |
|
decreases expression |
ISO |
20 |
11,920,816 |
11,982,468 |
RGD:6480464 |
CTD |
| G |
Col1a1 |
collagen, type I, alpha 1 |
|
decreases expression |
ISO |
10 |
83,622,438 |
83,639,368 |
RGD:6480464 |
CTD |
| G |
Col1a1 |
collagen, type I, alpha 1 |
|
increases expression |
EXP |
10 |
83,622,438 |
83,639,368 |
RGD:6480464 |
CTD |
| G |
Col4a1 |
collagen, type IV, alpha 1 |
|
affects expression |
ISO |
16 |
83,045,183 |
83,157,835 |
RGD:6480464 |
CTD |
| G |
Col5a1 |
collagen, type V, alpha 1 |
|
multiple interactions |
EXP |
3 |
6,826,169 |
6,971,054 |
RGD:6480464 |
CTD |
| G |
Col5a2 |
collagen, type V, alpha 2 |
|
multiple interactions |
EXP |
9 |
44,374,113 |
44,525,086 |
RGD:6480464 |
CTD |
| G |
Col5a3 |
collagen, type V, alpha 3 |
|
multiple interactions |
EXP |
8 |
19,789,061 |
19,834,241 |
RGD:6480464 |
CTD |
| G |
Col6a3 |
collagen, type VI, alpha 3 |
|
multiple interactions |
EXP |
9 |
89,990,129 |
90,043,697 |
RGD:6480464 |
CTD |
| G |
Colec12 |
collectin sub-family member 12 |
|
multiple interactions |
ISO |
18 |
996,297 |
1,188,288 |
RGD:6480464 |
CTD |
| G |
Colec12 |
collectin sub-family member 12 |
|
decreases expression |
ISO |
18 |
996,297 |
1,188,288 |
RGD:6480464 |
CTD |
| G |
Comt |
catechol-O-methyltransferase |
|
multiple interactions |
EXP |
11 |
84,561,591 |
84,581,713 |
RGD:6480464 |
CTD |
| G |
Copb2 |
coatomer protein complex, subunit beta 2 (beta prime) |
|
multiple interactions |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Coprs |
coordinator of PRMT5, differentiation stimulator |
|
multiple interactions |
ISO |
16 |
80,557,030 |
80,562,140 |
RGD:6480464 |
CTD |
| G |
Coprs |
coordinator of PRMT5, differentiation stimulator |
|
decreases expression |
ISO |
16 |
80,557,030 |
80,562,140 |
RGD:6480464 |
CTD |
| G |
Coq3 |
coenzyme Q3 homolog, methyltransferase (S. cerevisiae) |
|
multiple interactions |
ISO |
5 |
36,640,718 |
36,656,981 |
RGD:6480464 |
CTD |
| G |
Coq3 |
coenzyme Q3 homolog, methyltransferase (S. cerevisiae) |
|
decreases expression |
ISO |
5 |
36,640,718 |
36,656,981 |
RGD:6480464 |
CTD |
| G |
Cox15 |
cytochrome c oxidase assembly homolog 15 (yeast) |
|
decreases expression |
ISO |
1 |
247,077,102 |
247,093,757 |
RGD:6480464 |
CTD |
| G |
Cox7b2 |
cytochrome c oxidase subunit VIIb2 |
|
increases expression |
ISO |
14 |
39,267,491 |
39,267,844 |
RGD:6480464 |
CTD |
| G |
Cox7b2 |
cytochrome c oxidase subunit VIIb2 |
|
multiple interactions |
ISO |
14 |
39,267,491 |
39,267,844 |
RGD:6480464 |
CTD |
| G |
Cp |
ceruloplasmin (ferroxidase) |
|
multiple interactions |
EXP |
2 |
105,086,278 |
105,135,367 |
RGD:6480464 |
CTD |
| G |
Cpa1 |
carboxypeptidase A1 (pancreatic) |
|
multiple interactions |
EXP |
4 |
57,549,260 |
57,555,361 |
RGD:6480464 |
CTD |
| G |
Cpd |
carboxypeptidase D |
|
multiple interactions |
ISO |
10 |
67,327,272 |
67,390,836 |
RGD:6480464 |
CTD |
| G |
Cpd |
carboxypeptidase D |
|
increases expression |
ISO |
10 |
67,327,272 |
67,390,836 |
RGD:6480464 |
CTD |
| G |
Cpd |
carboxypeptidase D |
|
multiple interactions |
EXP |
10 |
67,327,272 |
67,390,836 |
RGD:6480464 |
CTD |
| G |
Cpe |
carboxypeptidase E |
|
multiple interactions |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Cpeb2 |
cytoplasmic polyadenylation element binding protein 2 |
|
multiple interactions |
ISO |
14 |
72,955,778 |
73,007,518 |
RGD:6480464 |
CTD |
| G |
Cpeb2 |
cytoplasmic polyadenylation element binding protein 2 |
|
decreases expression |
ISO |
14 |
72,955,778 |
73,007,518 |
RGD:6480464 |
CTD |
| G |
Cpeb3 |
cytoplasmic polyadenylation element binding protein 3 |
|
multiple interactions |
ISO |
1 |
241,298,277 |
241,444,908 |
RGD:6480464 |
CTD |
| G |
Cpeb3 |
cytoplasmic polyadenylation element binding protein 3 |
|
increases expression |
ISO |
1 |
241,298,277 |
241,444,908 |
RGD:6480464 |
CTD |
| G |
Cpox |
coproporphyrinogen oxidase |
|
increases expression |
ISO |
11 |
42,748,703 |
42,758,686 |
RGD:6480464 |
CTD |
| G |
Cpxm2 |
carboxypeptidase X (M14 family), member 2 |
|
decreases expression |
ISO |
1 |
191,510,790 |
191,624,219 |
RGD:6480464 |
CTD |
| G |
Cradd |
CASP2 and RIPK1 domain containing adaptor with death domain |
|
decreases expression |
ISO |
7 |
32,504,279 |
32,517,581 |
RGD:6480464 |
CTD |
| G |
Creb1 |
cAMP responsive element binding protein 1 |
|
multiple interactions |
EXP |
9 |
63,170,785 |
63,234,727 |
RGD:6480464 |
CTD |
| G |
Creb1 |
cAMP responsive element binding protein 1 |
|
multiple interactions |
EXP |
9 |
63,170,785 |
63,234,727 |
RGD:6480464 |
CTD |
| G |
Creb1 |
cAMP responsive element binding protein 1 |
|
increases phosphorylation |
EXP |
9 |
63,170,785 |
63,234,727 |
RGD:6480464 |
CTD |
| G |
Creb3 |
cAMP responsive element binding protein 3 |
|
multiple interactions |
ISO |
5 |
60,040,874 |
60,045,512 |
RGD:6480464 |
CTD |
| G |
Creb3 |
cAMP responsive element binding protein 3 |
|
increases expression |
ISO |
5 |
60,040,874 |
60,045,512 |
RGD:6480464 |
CTD |
| G |
Creb3l1 |
cAMP responsive element binding protein 3-like 1 |
|
multiple interactions |
ISO |
3 |
76,361,149 |
76,401,633 |
RGD:6480464 |
CTD |
| G |
Creb3l1 |
cAMP responsive element binding protein 3-like 1 |
|
increases expression |
ISO |
3 |
76,361,149 |
76,401,633 |
RGD:6480464 |
CTD |
| G |
Crebbp |
CREB binding protein |
|
increases expression |
ISO |
10 |
11,598,680 |
11,724,122 |
RGD:6480464 |
CTD |
| G |
Crh |
corticotropin releasing hormone |
|
multiple interactions |
EXP |
2 |
104,764,023 |
104,765,887 |
RGD:6480464 |
CTD |
| G |
Crisp1 |
cysteine-rich secretory protein 1 |
|
multiple interactions |
EXP |
9 |
16,975,151 |
17,002,149 |
RGD:6480464 |
CTD |
| G |
Crk |
v-crk sarcoma virus CT10 oncogene homolog (avian) |
|
multiple interactions |
EXP |
10 |
63,017,662 |
63,040,420 |
RGD:6480464 |
CTD |
| G |
Cryab |
crystallin, alpha B |
|
multiple interactions |
ISO |
8 |
54,107,824 |
54,111,502 |
RGD:6480464 |
CTD |
| G |
Cryab |
crystallin, alpha B |
|
increases expression |
ISO |
8 |
54,107,824 |
54,111,502 |
RGD:6480464 |
CTD |
| G |
Csad |
cysteine sulfinic acid decarboxylase |
|
increases expression |
ISO |
7 |
140,917,995 |
140,944,405 |
RGD:6480464 |
CTD |
| G |
Csad |
cysteine sulfinic acid decarboxylase |
|
decreases secretion |
EXP |
7 |
140,917,995 |
140,944,405 |
RGD:6480464 |
CTD |
| G |
Cse1l |
CSE1 chromosome segregation 1-like (yeast) |
|
multiple interactions |
ISO |
3 |
158,061,678 |
158,100,065 |
RGD:6480464 |
CTD |
| G |
Cse1l |
CSE1 chromosome segregation 1-like (yeast) |
|
decreases expression |
ISO |
3 |
158,061,678 |
158,100,065 |
RGD:6480464 |
CTD |
| G |
Csf1 |
colony stimulating factor 1 (macrophage) |
|
increases expression |
ISO |
2 |
203,292,765 |
203,307,968 |
RGD:6480464 |
CTD |
| G |
Ctsl1 |
cathepsin L1 |
|
decreases expression |
ISO |
17 |
6,288,013 |
6,294,174 |
RGD:6480464 |
CTD |
| G |
Ctsl1 |
cathepsin L1 |
|
multiple interactions |
EXP |
17 |
6,288,013 |
6,294,174 |
RGD:6480464 |
CTD |
| G |
Ctu2 |
cytosolic thiouridylase subunit 2 homolog (S. pombe) |
|
multiple interactions |
ISO |
19 |
52,765,786 |
52,771,016 |
RGD:6480464 |
CTD |
| G |
Ctu2 |
cytosolic thiouridylase subunit 2 homolog (S. pombe) |
|
decreases expression |
ISO |
19 |
52,765,786 |
52,771,016 |
RGD:6480464 |
CTD |
| G |
Cuzd1 |
CUB and zona pellucida-like domains 1 |
|
increases expression |
ISO |
1 |
190,887,527 |
190,900,654 |
RGD:6480464 |
CTD |
| G |
Cxadr |
coxsackie virus and adenovirus receptor |
|
multiple interactions |
ISO |
11 |
17,193,505 |
17,241,549 |
RGD:6480464 |
CTD |
| G |
Cxadr |
coxsackie virus and adenovirus receptor |
|
increases expression |
ISO |
11 |
17,193,505 |
17,241,549 |
RGD:6480464 |
CTD |
| G |
Cxcl10 |
chemokine (C-X-C motif) ligand 10 |
|
increases expression |
ISO |
14 |
17,265,986 |
17,268,183 |
RGD:6480464 |
CTD |
| G |
Cxcl11 |
chemokine (C-X-C motif) ligand 11 |
|
increases expression |
ISO |
14 |
17,250,648 |
17,253,423 |
RGD:6480464 |
CTD |
| G |
Cxcl11 |
chemokine (C-X-C motif) ligand 11 |
|
multiple interactions |
ISO |
14 |
17,250,648 |
17,253,423 |
RGD:6480464 |
CTD |
| G |
Cxcl9 |
chemokine (C-X-C motif) ligand 9 |
|
increases expression |
ISO |
14 |
17,284,085 |
17,288,996 |
RGD:6480464 |
CTD |
| G |
Cxcr4 |
chemokine (C-X-C motif) receptor 4 |
|
multiple interactions |
ISO |
13 |
41,308,286 |
41,312,190 |
RGD:6480464 |
CTD |
| G |
Cxcr4 |
chemokine (C-X-C motif) receptor 4 |
|
increases expression |
ISO |
13 |
41,308,286 |
41,312,190 |
RGD:6480464 |
CTD |
| G |
Cxcr7 |
chemokine (C-X-C motif) receptor 7 |
|
decreases expression |
ISO |
9 |
89,343,528 |
89,355,053 |
RGD:6480464 |
CTD |
| G |
Cxcr7 |
chemokine (C-X-C motif) receptor 7 |
|
multiple interactions |
ISO |
9 |
89,343,528 |
89,355,053 |
RGD:6480464 |
CTD |
| G |
Cyb561d1 |
cytochrome b561 family, member D1 |
|
multiple interactions |
ISO |
2 |
203,760,897 |
203,765,691 |
RGD:6480464 |
CTD |
| G |
Cyb561d1 |
cytochrome b561 family, member D1 |
|
increases expression |
ISO |
2 |
203,760,897 |
203,765,691 |
RGD:6480464 |
CTD |
| G |
Cyb561d2 |
cytochrome b561 family, member D2 |
|
multiple interactions |
ISO |
8 |
112,787,042 |
112,789,564 |
RGD:6480464 |
CTD |
| G |
Cyb561d2 |
cytochrome b561 family, member D2 |
|
increases expression |
ISO |
8 |
112,787,042 |
112,789,564 |
RGD:6480464 |
CTD |
| G |
Cyp11a1 |
cytochrome P450, family 11, subfamily a, polypeptide 1 |
|
multiple interactions |
ISO |
8 |
61,793,976 |
61,805,308 |
RGD:6480464 |
CTD |
| G |
Cyp11a1 |
cytochrome P450, family 11, subfamily a, polypeptide 1 |
|
decreases expression |
ISO |
8 |
61,793,976 |
61,805,308 |
RGD:6480464 |
CTD |
| G |
Cyp11a1 |
cytochrome P450, family 11, subfamily a, polypeptide 1 |
|
increases expression |
ISO |
8 |
61,793,976 |
61,805,308 |
RGD:6480464 |
CTD |
| G |
Cyp11a1 |
cytochrome P450, family 11, subfamily a, polypeptide 1 |
|
affects chemical synthesis |
ISO |
8 |
61,793,976 |
61,805,308 |
RGD:6480464 |
CTD |
| G |
Cyp11a1 |
cytochrome P450, family 11, subfamily a, polypeptide 1 |
|
multiple interactions |
EXP |
8 |
61,793,976 |
61,805,308 |
RGD:6480464 |
CTD |
| G |
Cyp11a1 |
cytochrome P450, family 11, subfamily a, polypeptide 1 |
|
multiple interactions |
EXP |
8 |
61,793,976 |
61,805,308 |
RGD:6480464 |
CTD |
| G |
Cyp11a1 |
cytochrome P450, family 11, subfamily a, polypeptide 1 |
|
increases expression |
EXP |
8 |
61,793,976 |
61,805,308 |
RGD:6480464 |
CTD |
| G |
Cyp11b1 |
cytochrome P450, family 11, subfamily b, polypeptide 1 |
|
decreases expression |
EXP |
7 |
112,977,395 |
112,984,080 |
RGD:6480464 |
CTD |
| G |
Cyp11b1 |
cytochrome P450, family 11, subfamily b, polypeptide 1 |
|
decreases activity |
EXP |
7 |
112,977,395 |
112,984,080 |
RGD:6480464 |
CTD |
| G |
Cyp11b2 |
cytochrome P450, family 11, subfamily b, polypeptide 2 |
|
increases chemical synthesis |
ISO |
7 |
113,043,365 |
113,049,779 |
RGD:6480464 |
CTD |
| G |
Cyp17a1 |
cytochrome P450, family 17, subfamily a, polypeptide 1 |
|
affects abundance |
ISO |
1 |
251,965,458 |
251,971,449 |
RGD:6480464 |
CTD |
| G |
Cyp17a1 |
cytochrome P450, family 17, subfamily a, polypeptide 1 |
|
decreases expression |
ISO |
1 |
251,965,458 |
251,971,449 |
RGD:6480464 |
CTD |
| G |
Cyp17a1 |
cytochrome P450, family 17, subfamily a, polypeptide 1 |
|
multiple interactions |
ISO |
1 |
251,965,458 |
251,971,449 |
RGD:6480464 |
CTD |
| G |
Cyp17a1 |
cytochrome P450, family 17, subfamily a, polypeptide 1 |
|
affects chemical synthesis |
ISO |
1 |
251,965,458 |
251,971,449 |
RGD:6480464 |
CTD |
| G |
Cyp17a1 |
cytochrome P450, family 17, subfamily a, polypeptide 1 |
|
multiple interactions |
ISO |
1 |
251,965,458 |
251,971,449 |
RGD:6480464 |
CTD |
| G |
Cyp17a1 |
cytochrome P450, family 17, subfamily a, polypeptide 1 |
|
decreases expression |
ISO |
1 |
251,965,458 |
251,971,449 |
RGD:6480464 |
CTD |
| G |
Cyp17a1 |
cytochrome P450, family 17, subfamily a, polypeptide 1 |
|
multiple interactions |
EXP |
1 |
251,965,458 |
251,971,449 |
RGD:6480464 |
CTD |
| G |
Cyp17a1 |
cytochrome P450, family 17, subfamily a, polypeptide 1 |
|
multiple interactions |
EXP |
1 |
251,965,458 |
251,971,449 |
RGD:6480464 |
CTD |
| G |
Cyp17a1 |
cytochrome P450, family 17, subfamily a, polypeptide 1 |
|
multiple interactions |
EXP |
1 |
251,965,458 |
251,971,449 |
RGD:6480464 |
CTD |
| G |
Cyp19a1 |
cytochrome P450, family 19, subfamily a, polypeptide 1 |
|
affects abundance |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Cyp19a1 |
cytochrome P450, family 19, subfamily a, polypeptide 1 |
|
affects metabolic processing |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Cyp19a1 |
cytochrome P450, family 19, subfamily a, polypeptide 1 |
|
multiple interactions |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Cyp19a1 |
cytochrome P450, family 19, subfamily a, polypeptide 1 |
|
multiple interactions |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Cyp19a1 |
cytochrome P450, family 19, subfamily a, polypeptide 1 |
|
multiple interactions |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Cyp19a1 |
cytochrome P450, family 19, subfamily a, polypeptide 1 |
|
multiple interactions |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Cyp19a1 |
cytochrome P450, family 19, subfamily a, polypeptide 1 |
|
multiple interactions |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Cyp19a1 |
cytochrome P450, family 19, subfamily a, polypeptide 1 |
|
decreases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Cyp19a1 |
cytochrome P450, family 19, subfamily a, polypeptide 1 |
|
affects metabolic processing |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Cyp19a1 |
cytochrome P450, family 19, subfamily a, polypeptide 1 |
|
increases metabolic processing |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Cyp19a1 |
cytochrome P450, family 19, subfamily a, polypeptide 1 |
|
increases expression |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Cyp19a1 |
cytochrome P450, family 19, subfamily a, polypeptide 1 |
|
increases expression |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Cyp1a1 |
cytochrome P450, family 1, subfamily a, polypeptide 1 |
|
increases hydroxylation |
ISO |
8 |
61,462,207 |
61,468,237 |
RGD:6480464 |
CTD |
| G |
Cyp1a1 |
cytochrome P450, family 1, subfamily a, polypeptide 1 |
|
affects metabolic processing |
EXP |
8 |
61,462,207 |
61,468,237 |
RGD:6480464 |
CTD |
| G |
Cyp1a1 |
cytochrome P450, family 1, subfamily a, polypeptide 1 |
|
multiple interactions |
ISO |
8 |
61,462,207 |
61,468,237 |
RGD:6480464 |
CTD |
| G |
Cyp1a1 |
cytochrome P450, family 1, subfamily a, polypeptide 1 |
|
multiple interactions |
EXP |
8 |
61,462,207 |
61,468,237 |
RGD:6480464 |
CTD |
| G |
Cyp24a1 |
cytochrome P450, family 24, subfamily a, polypeptide 1 |
|
affects expression |
ISO |
3 |
161,542,131 |
161,553,801 |
RGD:6480464 |
CTD |
| G |
Cyp24a1 |
cytochrome P450, family 24, subfamily a, polypeptide 1 |
|
multiple interactions |
ISO |
3 |
161,542,131 |
161,553,801 |
RGD:6480464 |
CTD |
| G |
Cyp24a1 |
cytochrome P450, family 24, subfamily a, polypeptide 1 |
|
increases expression |
ISO |
3 |
161,542,131 |
161,553,801 |
RGD:6480464 |
CTD |
| G |
Cyp2a1 |
cytochrome P450, family 2, subfamily a, polypeptide 1 |
|
affects metabolic processing |
EXP |
1 |
82,006,828 |
82,020,282 |
RGD:6480464 |
CTD |
| G |
Cyp2a2 |
cytochrome P450, family 2, subfamily a, polypeptide 2 |
|
affects metabolic processing |
EXP |
1 |
82,039,229 |
82,064,293 |
RGD:6480464 |
CTD |
| G |
Cyp2a3 |
cytochrome P450, family 2, subfamily a, polypeptide 3 |
|
multiple interactions |
ISO |
1 |
81,944,896 |
81,953,007 |
RGD:6480464 |
CTD |
| G |
Cyp2a3 |
cytochrome P450, family 2, subfamily a, polypeptide 3 |
|
affects metabolic processing |
EXP |
1 |
81,944,896 |
81,953,007 |
RGD:6480464 |
CTD |
| G |
Cyp2a3 |
cytochrome P450, family 2, subfamily a, polypeptide 3 |
|
increases metabolic processing |
ISO |
1 |
81,944,896 |
81,953,007 |
RGD:6480464 |
CTD |
| G |
Cyp2a3 |
cytochrome P450, family 2, subfamily a, polypeptide 3 |
|
increases expression |
ISO |
1 |
81,944,896 |
81,953,007 |
RGD:6480464 |
CTD |
| G |
Cyp2b1 |
cytochrome P450, family 2, subfamily b, polypeptide 1 |
|
affects metabolic processing |
EXP |
1 |
81,266,828 |
81,290,471 |
RGD:6480464 |
CTD |
| G |
Cyp2b1 |
cytochrome P450, family 2, subfamily b, polypeptide 1 |
|
decreases expression |
ISO |
1 |
81,266,828 |
81,290,471 |
RGD:6480464 |
CTD |
| G |
Cyp2b13 |
cytochrome P450, family 2, subfamily b, polypeptide 13 |
|
decreases expression |
ISO |
1 |
81,408,436 |
81,582,029 |
RGD:6480464 |
CTD |
| G |
Cyp2b2 |
cytochrome P450, family 2, subfamily b, polypeptide 2 |
|
increases metabolic processing |
ISO |
1 |
81,345,425 |
81,359,415 |
RGD:6480464 |
CTD |
| G |
Cyp2b3 |
cytochrome P450, family 2, subfamily b, polypeptide 3 |
|
decreases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Cyp2c11 |
cytochrome P450, subfamily 2, polypeptide 11 |
|
affects metabolic processing |
EXP |
1 |
243,281,320 |
243,320,945 |
RGD:6480464 |
CTD |
| G |
Cyp2c11 |
cytochrome P450, subfamily 2, polypeptide 11 |
|
increases expression |
EXP |
1 |
243,281,320 |
243,320,945 |
RGD:6480464 |
CTD |
| G |
Cyp2c13 |
cytochrome P450, family 2, subfamily c, polypeptide 13 |
|
decreases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Cyp2d3 |
cytochrome P450, family 2, subfamily d, polypeptide 3 |
|
increases expression |
ISO |
7 |
120,778,783 |
120,783,140 |
RGD:6480464 |
CTD |
| G |
Cyp2e1 |
cytochrome P450, family 2, subfamily e, polypeptide 1 |
|
increases expression |
ISO |
1 |
200,918,521 |
200,928,919 |
RGD:6480464 |
CTD |
| G |
Cyp2e1 |
cytochrome P450, family 2, subfamily e, polypeptide 1 |
|
increases expression |
ISO |
1 |
200,918,521 |
200,928,919 |
RGD:6480464 |
CTD |
| G |
Cyp2s1 |
cytochrome P450, family 2, subfamily s, polypeptide 1 |
|
multiple interactions |
ISO |
1 |
81,008,464 |
81,023,486 |
RGD:6480464 |
CTD |
| G |
Cyp2s1 |
cytochrome P450, family 2, subfamily s, polypeptide 1 |
|
increases expression |
ISO |
1 |
81,008,464 |
81,023,486 |
RGD:6480464 |
CTD |
| G |
Cyp2u1 |
cytochrome P450, family 2, subfamily u, polypeptide 1 |
|
multiple interactions |
ISO |
2 |
228,771,187 |
228,788,636 |
RGD:6480464 |
CTD |
| G |
Cyp2u1 |
cytochrome P450, family 2, subfamily u, polypeptide 1 |
|
increases expression |
ISO |
2 |
228,771,187 |
228,788,636 |
RGD:6480464 |
CTD |
| G |
Cyp3a2 |
cytochrome P450, family 3, subfamily a, polypeptide 2 |
|
increases hydroxylation |
EXP |
12 |
9,517,016 |
9,541,000 |
RGD:6480464 |
CTD |
| G |
Cyp3a2 |
cytochrome P450, family 3, subfamily a, polypeptide 2 |
|
multiple interactions |
ISO |
12 |
9,517,016 |
9,541,000 |
RGD:6480464 |
CTD |
| G |
Cyp3a2 |
cytochrome P450, family 3, subfamily a, polypeptide 2 |
|
multiple interactions |
ISO |
12 |
9,517,016 |
9,541,000 |
RGD:6480464 |
CTD |
| G |
Cyp3a2 |
cytochrome P450, family 3, subfamily a, polypeptide 2 |
|
multiple interactions |
EXP |
12 |
9,517,016 |
9,541,000 |
RGD:6480464 |
CTD |
| G |
Cyp3a2 |
cytochrome P450, family 3, subfamily a, polypeptide 2 |
|
affects hydroxylation |
ISO |
12 |
9,517,016 |
9,541,000 |
RGD:6480464 |
CTD |
| G |
Cyp3a2 |
cytochrome P450, family 3, subfamily a, polypeptide 2 |
|
affects metabolic processing |
ISO |
12 |
9,517,016 |
9,541,000 |
RGD:6480464 |
CTD |
| G |
Cyp3a2 |
cytochrome P450, family 3, subfamily a, polypeptide 2 |
|
increases hydrolysis |
ISO |
12 |
9,517,016 |
9,541,000 |
RGD:6480464 |
CTD |
| G |
Cyp3a2 |
cytochrome P450, family 3, subfamily a, polypeptide 2 |
|
increases hydroxylation |
ISO |
12 |
9,517,016 |
9,541,000 |
RGD:6480464 |
CTD |
| G |
Cyp3a2 |
cytochrome P450, family 3, subfamily a, polypeptide 2 |
|
increases metabolic processing |
ISO |
12 |
9,517,016 |
9,541,000 |
RGD:6480464 |
CTD |
| G |
Cyp3a2 |
cytochrome P450, family 3, subfamily a, polypeptide 2 |
|
multiple interactions |
ISO |
12 |
9,517,016 |
9,541,000 |
RGD:6480464 |
CTD |
| G |
Cyp3a2 |
cytochrome P450, family 3, subfamily a, polypeptide 2 |
|
multiple interactions |
ISO |
12 |
9,517,016 |
9,541,000 |
RGD:6480464 |
CTD |
| G |
Cyp3a2 |
cytochrome P450, family 3, subfamily a, polypeptide 2 |
|
multiple interactions |
ISO |
12 |
9,517,016 |
9,541,000 |
RGD:6480464 |
CTD |
| G |
Cyp3a2 |
cytochrome P450, family 3, subfamily a, polypeptide 2 |
|
multiple interactions |
ISO |
12 |
9,517,016 |
9,541,000 |
RGD:6480464 |
CTD |
| G |
Cyp3a2 |
cytochrome P450, family 3, subfamily a, polypeptide 2 |
|
decreases expression |
ISO |
12 |
9,517,016 |
9,541,000 |
RGD:6480464 |
CTD |
| G |
Cyp3a23/3a1 |
cytochrome P450, family 3, subfamily a, polypeptide 23/polypeptide 1 |
|
decreases expression |
ISO |
12 |
9,567,120 |
9,595,974 |
RGD:6480464 |
CTD |
| G |
Cyp3a9 |
cytochrome P450, family 3, subfamily a, polypeptide 9 |
|
increases hydroxylation |
ISO |
12 |
17,164,384 |
17,204,589 |
RGD:6480464 |
CTD |
| G |
Cyp3a9 |
cytochrome P450, family 3, subfamily a, polypeptide 9 |
|
increases expression |
ISO |
12 |
17,164,384 |
17,204,589 |
RGD:6480464 |
CTD |
| G |
Cyp3a9 |
cytochrome P450, family 3, subfamily a, polypeptide 9 |
|
multiple interactions |
ISO |
12 |
17,164,384 |
17,204,589 |
RGD:6480464 |
CTD |
| G |
Cyp3a9 |
cytochrome P450, family 3, subfamily a, polypeptide 9 |
|
affects metabolic processing |
EXP |
12 |
17,164,384 |
17,204,589 |
RGD:6480464 |
CTD |
| G |
Cyp46a1 |
cytochrome P450, family 46, subfamily a, polypeptide 1 |
|
increases hydroxylation |
ISO |
6 |
132,700,554 |
132,731,982 |
RGD:6480464 |
CTD |
| G |
Cyp4b1 |
cytochrome P450, family 4, subfamily b, polypeptide 1 |
|
increases expression |
EXP |
5 |
135,917,327 |
135,934,636 |
RGD:6480464 |
CTD |
| G |
Cyp7a1 |
cytochrome P450, family 7, subfamily a, polypeptide 1 |
|
decreases expression |
ISO |
5 |
19,707,159 |
19,716,856 |
RGD:6480464 |
CTD |
| G |
Cyp7b1 |
cytochrome P450, family 7, subfamily b, polypeptide 1 |
|
increases expression |
ISO |
2 |
103,102,679 |
103,271,273 |
RGD:6480464 |
CTD |
| G |
Cyr61 |
cysteine-rich, angiogenic inducer, 61 |
|
increases expression |
ISO |
2 |
243,824,303 |
243,827,262 |
RGD:6480464 |
CTD |
| G |
Cystm1 |
cysteine-rich transmembrane module containing 1 |
|
multiple interactions |
ISO |
18 |
28,984,344 |
29,031,445 |
RGD:6480464 |
CTD |
| G |
Cystm1 |
cysteine-rich transmembrane module containing 1 |
|
increases expression |
ISO |
18 |
28,984,344 |
29,031,445 |
RGD:6480464 |
CTD |
| G |
Dapk1 |
death associated protein kinase 1 |
|
decreases expression |
ISO |
17 |
9,617,607 |
9,779,457 |
RGD:6480464 |
CTD |
| G |
Dek |
DEK oncogene |
|
decreases expression |
ISO |
17 |
23,633,551 |
23,655,507 |
RGD:6480464 |
CTD |
| G |
Dek |
DEK oncogene |
|
multiple interactions |
ISO |
17 |
23,633,551 |
23,655,507 |
RGD:6480464 |
CTD |
| G |
Dennd1c |
DENN/MADD domain containing 1C |
|
multiple interactions |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Dennd1c |
DENN/MADD domain containing 1C |
|
increases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Depdc1 |
DEP domain containing 1 |
|
multiple interactions |
ISO |
2 |
257,763,301 |
257,796,571 |
RGD:6480464 |
CTD |
| G |
Depdc1 |
DEP domain containing 1 |
|
decreases expression |
ISO |
2 |
257,763,301 |
257,796,571 |
RGD:6480464 |
CTD |
| G |
Depdc1b |
DEP domain containing 1B |
|
decreases expression |
ISO |
2 |
39,632,210 |
39,700,199 |
RGD:6480464 |
CTD |
| G |
Depdc1b |
DEP domain containing 1B |
|
multiple interactions |
ISO |
2 |
39,632,210 |
39,700,199 |
RGD:6480464 |
CTD |
| G |
Dffb |
DNA fragmentation factor, 40kDa, beta polypeptide (caspase-activated DNase) |
|
multiple interactions |
ISO |
5 |
170,750,718 |
170,762,034 |
RGD:6480464 |
CTD |
| G |
Dffb |
DNA fragmentation factor, 40kDa, beta polypeptide (caspase-activated DNase) |
|
decreases expression |
ISO |
5 |
170,750,718 |
170,762,034 |
RGD:6480464 |
CTD |
| G |
Dgat2 |
diacylglycerol O-acyltransferase 2 |
|
multiple interactions |
EXP |
1 |
156,447,588 |
156,478,740 |
RGD:6480464 |
CTD |
| G |
Dgka |
diacylglycerol kinase, alpha |
|
multiple interactions |
ISO |
7 |
2,018,858 |
2,045,336 |
RGD:6480464 |
CTD |
| G |
Dgka |
diacylglycerol kinase, alpha |
|
increases expression |
ISO |
7 |
2,018,858 |
2,045,336 |
RGD:6480464 |
CTD |
| G |
Dgkh |
diacylglycerol kinase, eta |
|
multiple interactions |
ISO |
15 |
59,730,745 |
59,883,806 |
RGD:6480464 |
CTD |
| G |
Dgkh |
diacylglycerol kinase, eta |
|
decreases expression |
ISO |
15 |
59,730,745 |
59,883,806 |
RGD:6480464 |
CTD |
| G |
Dhrs2 |
dehydrogenase/reductase (SDR family) member 2 |
|
multiple interactions |
ISO |
15 |
33,286,599 |
33,337,467 |
RGD:6480464 |
CTD |
| G |
Dhrs2 |
dehydrogenase/reductase (SDR family) member 2 |
|
increases expression |
ISO |
15 |
33,286,599 |
33,337,467 |
RGD:6480464 |
CTD |
| G |
Dhrs3 |
dehydrogenase/reductase (SDR family) member 3 |
|
increases expression |
ISO |
5 |
163,341,856 |
163,375,604 |
RGD:6480464 |
CTD |
| G |
Dhrs3 |
dehydrogenase/reductase (SDR family) member 3 |
|
multiple interactions |
ISO |
5 |
163,341,856 |
163,375,604 |
RGD:6480464 |
CTD |
| G |
Diaph3 |
diaphanous homolog 3 (Drosophila) |
|
multiple interactions |
ISO |
15 |
68,905,784 |
69,267,707 |
RGD:6480464 |
CTD |
| G |
Diaph3 |
diaphanous homolog 3 (Drosophila) |
|
decreases expression |
ISO |
15 |
68,905,784 |
69,267,707 |
RGD:6480464 |
CTD |
| G |
Dis3l2 |
DIS3 mitotic control homolog (S. cerevisiae)-like 2 |
|
multiple interactions |
ISO |
9 |
85,470,810 |
85,855,679 |
RGD:6480464 |
CTD |
| G |
Dis3l2 |
DIS3 mitotic control homolog (S. cerevisiae)-like 2 |
|
increases expression |
ISO |
9 |
85,470,810 |
85,855,679 |
RGD:6480464 |
CTD |
| G |
Disp1 |
dispatched homolog 1 (Drosophila) |
|
multiple interactions |
ISO |
13 |
99,095,659 |
99,242,282 |
RGD:6480464 |
CTD |
| G |
Disp1 |
dispatched homolog 1 (Drosophila) |
|
increases expression |
ISO |
13 |
99,095,659 |
99,242,282 |
RGD:6480464 |
CTD |
| G |
Dlgap5 |
discs, large (Drosophila) homolog-associated protein 5 |
|
multiple interactions |
ISO |
15 |
23,340,955 |
23,375,755 |
RGD:6480464 |
CTD |
| G |
Dlgap5 |
discs, large (Drosophila) homolog-associated protein 5 |
|
decreases expression |
ISO |
15 |
23,340,955 |
23,375,755 |
RGD:6480464 |
CTD |
| G |
Dmbx1 |
diencephalon/mesencephalon homeobox 1 |
|
multiple interactions |
ISO |
5 |
136,177,328 |
136,188,212 |
RGD:6480464 |
CTD |
| G |
Dmbx1 |
diencephalon/mesencephalon homeobox 1 |
|
decreases expression |
ISO |
5 |
136,177,328 |
136,188,212 |
RGD:6480464 |
CTD |
| G |
Dmgdh |
dimethylglycine dehydrogenase |
|
multiple interactions |
ISO |
2 |
23,976,563 |
24,052,766 |
RGD:6480464 |
CTD |
| G |
Dmgdh |
dimethylglycine dehydrogenase |
|
decreases expression |
ISO |
2 |
23,976,563 |
24,052,766 |
RGD:6480464 |
CTD |
| G |
Dna2 |
DNA replication helicase 2 homolog (yeast) |
|
multiple interactions |
ISO |
20 |
25,288,326 |
25,316,851 |
RGD:6480464 |
CTD |
| G |
Dna2 |
DNA replication helicase 2 homolog (yeast) |
|
decreases expression |
ISO |
20 |
25,288,326 |
25,316,851 |
RGD:6480464 |
CTD |
| G |
Dnajb14 |
DnaJ (Hsp40) homolog, subfamily B, member 14 |
|
multiple interactions |
ISO |
2 |
235,356,253 |
235,399,743 |
RGD:6480464 |
CTD |
| G |
Dnajb14 |
DnaJ (Hsp40) homolog, subfamily B, member 14 |
|
increases expression |
ISO |
2 |
235,356,253 |
235,399,743 |
RGD:6480464 |
CTD |
| G |
Dnajb3 |
DnaJ (Hsp40) homolog, subfamily B, member 3 |
|
multiple interactions |
ISO |
9 |
87,085,458 |
87,086,471 |
RGD:6480464 |
CTD |
| G |
Dnajb3 |
DnaJ (Hsp40) homolog, subfamily B, member 3 |
|
increases expression |
ISO |
9 |
87,085,458 |
87,086,471 |
RGD:6480464 |
CTD |
| G |
Dnajc3 |
DnaJ (Hsp40) homolog, subfamily C, member 3 |
|
multiple interactions |
ISO |
15 |
103,881,634 |
103,921,295 |
RGD:6480464 |
CTD |
| G |
Dnajc3 |
DnaJ (Hsp40) homolog, subfamily C, member 3 |
|
increases expression |
ISO |
15 |
103,881,634 |
103,921,295 |
RGD:6480464 |
CTD |
| G |
Dnajc9 |
DnaJ (Hsp40) homolog, subfamily C, member 9 |
|
multiple interactions |
ISO |
15 |
4,152,480 |
4,156,756 |
RGD:6480464 |
CTD |
| G |
Dnajc9 |
DnaJ (Hsp40) homolog, subfamily C, member 9 |
|
decreases expression |
ISO |
15 |
4,152,480 |
4,156,756 |
RGD:6480464 |
CTD |
| G |
Dnd1 |
dead end homolog 1 (zebrafish) |
|
increases expression |
ISO |
18 |
29,464,691 |
29,467,315 |
RGD:6480464 |
CTD |
| G |
Dnd1 |
dead end homolog 1 (zebrafish) |
|
multiple interactions |
ISO |
18 |
29,464,691 |
29,467,315 |
RGD:6480464 |
CTD |
| G |
Dnmt1 |
DNA (cytosine-5-)-methyltransferase 1 |
|
multiple interactions |
ISO |
8 |
19,926,995 |
19,973,256 |
RGD:6480464 |
CTD |
| G |
Dnmt1 |
DNA (cytosine-5-)-methyltransferase 1 |
|
decreases expression |
ISO |
8 |
19,926,995 |
19,973,256 |
RGD:6480464 |
CTD |
| G |
Dnmt3b |
DNA (cytosine-5-)-methyltransferase 3 beta |
|
multiple interactions |
ISO |
3 |
144,030,737 |
144,069,265 |
RGD:6480464 |
CTD |
| G |
Dnmt3b |
DNA (cytosine-5-)-methyltransferase 3 beta |
|
decreases expression |
ISO |
3 |
144,030,737 |
144,069,265 |
RGD:6480464 |
CTD |
| G |
Dntt |
deoxynucleotidyltransferase, terminal |
|
decreases expression |
ISO |
1 |
246,199,856 |
246,231,792 |
RGD:6480464 |
CTD |
| G |
Dock8 |
dedicator of cytokinesis 8 |
|
increases expression |
ISO |
1 |
228,441,384 |
228,634,717 |
RGD:6480464 |
CTD |
| G |
Dock8 |
dedicator of cytokinesis 8 |
|
multiple interactions |
ISO |
1 |
228,441,384 |
228,634,717 |
RGD:6480464 |
CTD |
| G |
Dok2 |
docking protein 2 |
|
decreases expression |
ISO |
15 |
51,171,277 |
51,174,337 |
RGD:6480464 |
CTD |
| G |
Dok4 |
docking protein 4 |
|
multiple interactions |
ISO |
19 |
10,585,647 |
10,596,322 |
RGD:6480464 |
CTD |
| G |
Dok4 |
docking protein 4 |
|
increases expression |
ISO |
19 |
10,585,647 |
10,596,322 |
RGD:6480464 |
CTD |
| G |
Donson |
downstream neighbor of SON |
|
multiple interactions |
ISO |
11 |
31,652,219 |
31,661,872 |
RGD:6480464 |
CTD |
| G |
Donson |
downstream neighbor of SON |
|
decreases expression |
ISO |
11 |
31,652,219 |
31,661,872 |
RGD:6480464 |
CTD |
| G |
Dpf1 |
D4, zinc and double PHD fingers family 1 |
|
multiple interactions |
ISO |
1 |
84,444,143 |
84,452,889 |
RGD:6480464 |
CTD |
| G |
Dpf1 |
D4, zinc and double PHD fingers family 1 |
|
decreases expression |
ISO |
1 |
84,444,143 |
84,452,889 |
RGD:6480464 |
CTD |
| G |
Dsc1 |
desmocollin 1 |
|
multiple interactions |
ISO |
18 |
11,953,172 |
11,979,048 |
RGD:6480464 |
CTD |
| G |
Dsc1 |
desmocollin 1 |
|
decreases expression |
ISO |
18 |
11,953,172 |
11,979,048 |
RGD:6480464 |
CTD |
| G |
Dsc2 |
desmocollin 2 |
|
multiple interactions |
ISO |
18 |
11,902,185 |
11,933,989 |
RGD:6480464 |
CTD |
| G |
Dsc2 |
desmocollin 2 |
|
decreases expression |
ISO |
18 |
11,902,185 |
11,933,989 |
RGD:6480464 |
CTD |
| G |
Dsel |
dermatan sulfate epimerase-like |
|
decreases expression |
ISO |
13 |
19,394,146 |
19,398,749 |
RGD:6480464 |
CTD |
| G |
Dsel |
dermatan sulfate epimerase-like |
|
multiple interactions |
ISO |
13 |
19,394,146 |
19,398,749 |
RGD:6480464 |
CTD |
| G |
Dtl |
denticleless E3 ubiquitin protein ligase homolog (Drosophila) |
|
multiple interactions |
ISO |
13 |
107,603,353 |
107,640,812 |
RGD:6480464 |
CTD |
| G |
Dtl |
denticleless E3 ubiquitin protein ligase homolog (Drosophila) |
|
decreases expression |
ISO |
13 |
107,603,353 |
107,640,812 |
RGD:6480464 |
CTD |
| G |
Dtymk |
deoxythymidylate kinase (thymidylate kinase) |
|
multiple interactions |
ISO |
9 |
93,065,333 |
93,074,168 |
RGD:6480464 |
CTD |
| G |
Dtymk |
deoxythymidylate kinase (thymidylate kinase) |
|
decreases expression |
ISO |
9 |
93,065,333 |
93,074,168 |
RGD:6480464 |
CTD |
| G |
Duox1 |
dual oxidase 1 |
|
multiple interactions |
ISO |
3 |
109,095,250 |
109,128,415 |
RGD:6480464 |
CTD |
| G |
Duox1 |
dual oxidase 1 |
|
increases expression |
ISO |
3 |
109,095,250 |
109,128,415 |
RGD:6480464 |
CTD |
| G |
Dusp1 |
dual specificity phosphatase 1 |
|
multiple interactions |
ISO |
10 |
16,942,913 |
16,945,696 |
RGD:6480464 |
CTD |
| G |
Dusp1 |
dual specificity phosphatase 1 |
|
increases expression |
ISO |
10 |
16,942,913 |
16,945,696 |
RGD:6480464 |
CTD |
| G |
Dusp5 |
dual specificity phosphatase 5 |
|
multiple interactions |
ISO |
1 |
259,754,234 |
259,767,645 |
RGD:6480464 |
CTD |
| G |
Dusp5 |
dual specificity phosphatase 5 |
|
increases expression |
ISO |
1 |
259,754,234 |
259,767,645 |
RGD:6480464 |
CTD |
| G |
Dusp6 |
dual specificity phosphatase 6 |
|
decreases expression |
ISO |
7 |
36,893,264 |
36,897,494 |
RGD:6480464 |
CTD |
| G |
Dusp7 |
dual specificity phosphatase 7 |
|
decreases expression |
ISO |
8 |
111,510,358 |
111,515,989 |
RGD:6480464 |
CTD |
| G |
Dusp7 |
dual specificity phosphatase 7 |
|
multiple interactions |
ISO |
8 |
111,510,358 |
111,515,989 |
RGD:6480464 |
CTD |
| G |
Dut |
deoxyuridine triphosphatase |
|
multiple interactions |
ISO |
3 |
112,551,434 |
112,562,434 |
RGD:6480464 |
CTD |
| G |
Dut |
deoxyuridine triphosphatase |
|
decreases expression |
ISO |
3 |
112,551,434 |
112,562,434 |
RGD:6480464 |
CTD |
| G |
Dynlt3 |
dynein light chain Tctex-type 3 |
|
decreases expression |
ISO |
X |
25,480,916 |
25,490,479 |
RGD:6480464 |
CTD |
| G |
Dysf |
dysferlin |
|
increases expression |
ISO |
4 |
118,213,435 |
118,371,283 |
RGD:6480464 |
CTD |
| G |
Dysf |
dysferlin |
|
multiple interactions |
ISO |
4 |
118,213,435 |
118,371,283 |
RGD:6480464 |
CTD |
| G |
Dysf |
dysferlin |
|
affects expression |
ISO |
4 |
118,213,435 |
118,371,283 |
RGD:6480464 |
CTD |
| G |
E2f1 |
E2F transcription factor 1 |
|
multiple interactions |
ISO |
3 |
145,032,489 |
145,043,729 |
RGD:6480464 |
CTD |
| G |
E2f1 |
E2F transcription factor 1 |
|
decreases expression |
ISO |
3 |
145,032,489 |
145,043,729 |
RGD:6480464 |
CTD |
| G |
E2f7 |
E2F transcription factor 7 |
|
decreases expression |
ISO |
7 |
49,689,755 |
49,751,823 |
RGD:6480464 |
CTD |
| G |
E2f7 |
E2F transcription factor 7 |
|
multiple interactions |
ISO |
7 |
49,689,755 |
49,751,823 |
RGD:6480464 |
CTD |
| G |
E2f8 |
E2F transcription factor 8 |
|
multiple interactions |
ISO |
1 |
98,640,381 |
98,694,764 |
RGD:6480464 |
CTD |
| G |
E2f8 |
E2F transcription factor 8 |
|
decreases expression |
ISO |
1 |
98,640,381 |
98,694,764 |
RGD:6480464 |
CTD |
| G |
Eaf2 |
ELL associated factor 2 |
|
multiple interactions |
ISO |
11 |
65,763,410 |
65,809,967 |
RGD:6480464 |
CTD |
| G |
Eaf2 |
ELL associated factor 2 |
|
increases expression |
ISO |
11 |
65,763,410 |
65,809,967 |
RGD:6480464 |
CTD |
| G |
Ece1 |
endothelin converting enzyme 1 |
|
multiple interactions |
EXP |
5 |
156,635,656 |
156,735,783 |
RGD:6480464 |
CTD |
| G |
Ece1 |
endothelin converting enzyme 1 |
|
affects expression |
EXP |
5 |
156,635,656 |
156,735,783 |
RGD:6480464 |
CTD |
| G |
Eci3 |
enoyl-Coenzyme A delta isomerase 3 |
|
decreases expression |
ISO |
17 |
36,253,004 |
36,274,899 |
RGD:6480464 |
CTD |
| G |
Ect2 |
epithelial cell transforming sequence 2 oncogene |
|
multiple interactions |
ISO |
2 |
112,969,261 |
113,001,056 |
RGD:6480464 |
CTD |
| G |
Ect2 |
epithelial cell transforming sequence 2 oncogene |
|
decreases expression |
ISO |
2 |
112,969,261 |
113,001,056 |
RGD:6480464 |
CTD |
| G |
Edn1 |
endothelin 1 |
|
multiple interactions |
ISO |
17 |
28,303,886 |
28,309,775 |
RGD:6480464 |
CTD |
| G |
Edn1 |
endothelin 1 |
|
affects expression |
EXP |
17 |
28,303,886 |
28,309,775 |
RGD:6480464 |
CTD |
| G |
Edn1 |
endothelin 1 |
|
increases expression |
ISO |
17 |
28,303,886 |
28,309,775 |
RGD:6480464 |
CTD |
| G |
Ednra |
endothelin receptor type A |
|
affects expression |
EXP |
19 |
32,042,366 |
32,108,153 |
RGD:6480464 |
CTD |
| G |
Ednrb |
endothelin receptor type B |
|
affects expression |
EXP |
15 |
87,893,141 |
87,898,700 |
RGD:6480464 |
CTD |
| G |
Efnb2 |
ephrin B2 |
|
multiple interactions |
ISO |
16 |
86,187,639 |
86,228,023 |
RGD:6480464 |
CTD |
| G |
Efnb2 |
ephrin B2 |
|
decreases expression |
ISO |
16 |
86,187,639 |
86,228,023 |
RGD:6480464 |
CTD |
| G |
Eftud1 |
elongation factor Tu GTP binding domain containing 1 |
|
multiple interactions |
ISO |
1 |
138,920,620 |
139,044,342 |
RGD:6480464 |
CTD |
| G |
Eftud1 |
elongation factor Tu GTP binding domain containing 1 |
|
decreases expression |
ISO |
1 |
138,920,620 |
139,044,342 |
RGD:6480464 |
CTD |
| G |
Egf |
epidermal growth factor |
|
multiple interactions |
ISO |
2 |
227,103,900 |
227,195,062 |
RGD:6480464 |
CTD |
| G |
Egf |
epidermal growth factor |
|
increases expression |
ISO |
2 |
227,103,900 |
227,195,062 |
RGD:6480464 |
CTD |
| G |
Egf |
epidermal growth factor |
|
multiple interactions |
EXP |
2 |
227,103,900 |
227,195,062 |
RGD:6480464 |
CTD |
| G |
Egflam |
EGF-like, fibronectin type III and laminin G domains |
|
decreases expression |
ISO |
2 |
56,493,064 |
56,666,659 |
RGD:6480464 |
CTD |
| G |
Egfr |
epidermal growth factor receptor |
|
multiple interactions |
EXP |
14 |
97,617,358 |
97,788,211 |
RGD:6480464 |
CTD |
| G |
Egfr |
epidermal growth factor receptor |
|
increases expression |
ISO |
14 |
97,617,358 |
97,788,211 |
RGD:6480464 |
CTD |
| G |
Elmo2 |
engulfment and cell motility 2 |
|
multiple interactions |
ISO |
3 |
156,328,613 |
156,366,106 |
RGD:6480464 |
CTD |
| G |
Elmo2 |
engulfment and cell motility 2 |
|
increases expression |
ISO |
3 |
156,328,613 |
156,366,106 |
RGD:6480464 |
CTD |
| G |
Eme1 |
essential meiotic endonuclease 1 homolog 1 (S. pombe) |
|
decreases expression |
ISO |
10 |
83,279,086 |
83,285,091 |
RGD:6480464 |
CTD |
| G |
Eme1 |
essential meiotic endonuclease 1 homolog 1 (S. pombe) |
|
multiple interactions |
ISO |
10 |
83,279,086 |
83,285,091 |
RGD:6480464 |
CTD |
| G |
Emp1 |
epithelial membrane protein 1 |
|
multiple interactions |
ISO |
4 |
172,315,122 |
172,335,536 |
RGD:6480464 |
CTD |
| G |
Emp1 |
epithelial membrane protein 1 |
|
increases expression |
ISO |
4 |
172,315,122 |
172,335,536 |
RGD:6480464 |
CTD |
| G |
Entpd8 |
ectonucleoside triphosphate diphosphohydrolase 8 |
|
multiple interactions |
ISO |
3 |
5,229,747 |
5,258,064 |
RGD:6480464 |
CTD |
| G |
Entpd8 |
ectonucleoside triphosphate diphosphohydrolase 8 |
|
increases expression |
ISO |
3 |
5,229,747 |
5,258,064 |
RGD:6480464 |
CTD |
| G |
Epb41l3 |
erythrocyte membrane protein band 4.1-like 3 |
|
multiple interactions |
ISO |
9 |
108,303,607 |
108,426,942 |
RGD:6480464 |
CTD |
| G |
Epb41l3 |
erythrocyte membrane protein band 4.1-like 3 |
|
increases expression |
ISO |
9 |
108,303,607 |
108,426,942 |
RGD:6480464 |
CTD |
| G |
Epha1 |
Eph receptor A1 |
|
multiple interactions |
ISO |
4 |
70,127,872 |
70,142,309 |
RGD:6480464 |
CTD |
| G |
Epha1 |
Eph receptor A1 |
|
increases expression |
ISO |
4 |
70,127,872 |
70,142,309 |
RGD:6480464 |
CTD |
| G |
Epha7 |
Eph receptor A7 |
|
multiple interactions |
EXP |
5 |
44,728,037 |
44,878,332 |
RGD:6480464 |
CTD |
| G |
Ephb6 |
Eph receptor B6 |
|
multiple interactions |
ISO |
4 |
69,316,600 |
69,331,856 |
RGD:6480464 |
CTD |
| G |
Ephb6 |
Eph receptor B6 |
|
increases expression |
ISO |
4 |
69,316,600 |
69,331,856 |
RGD:6480464 |
CTD |
| G |
Epo |
erythropoietin |
|
multiple interactions |
ISO |
12 |
19,551,768 |
19,555,208 |
RGD:6480464 |
CTD |
| G |
Eps8l1 |
EPS8-like 1 |
|
increases expression |
ISO |
1 |
68,072,667 |
68,087,385 |
RGD:6480464 |
CTD |
| G |
Eps8l1 |
EPS8-like 1 |
|
multiple interactions |
ISO |
1 |
68,072,667 |
68,087,385 |
RGD:6480464 |
CTD |
| G |
Ercc6l |
excision repair cross-complementing rodent repair deficiency complementation group 6 - like |
|
multiple interactions |
ISO |
X |
90,195,080 |
90,212,006 |
RGD:6480464 |
CTD |
| G |
Ercc6l |
excision repair cross-complementing rodent repair deficiency complementation group 6 - like |
|
decreases expression |
ISO |
X |
90,195,080 |
90,212,006 |
RGD:6480464 |
CTD |
| G |
Ero1l |
ERO1-like (S. cerevisiae) |
|
increases expression |
ISO |
15 |
21,169,438 |
21,205,536 |
RGD:6480464 |
CTD |
| G |
Ero1l |
ERO1-like (S. cerevisiae) |
|
multiple interactions |
ISO |
15 |
21,169,438 |
21,205,536 |
RGD:6480464 |
CTD |
| G |
Errfi1 |
ERBB receptor feedback inhibitor 1 |
|
multiple interactions |
ISO |
5 |
168,012,683 |
168,025,963 |
RGD:6480464 |
CTD |
| G |
Errfi1 |
ERBB receptor feedback inhibitor 1 |
|
increases expression |
ISO |
5 |
168,012,683 |
168,025,963 |
RGD:6480464 |
CTD |
| G |
Esco2 |
establishment of cohesion 1 homolog 2 (S. cerevisiae) |
|
multiple interactions |
ISO |
15 |
45,239,871 |
45,254,898 |
RGD:6480464 |
CTD |
| G |
Exo5 |
exonuclease 5 |
|
multiple interactions |
ISO |
5 |
141,507,689 |
141,511,006 |
RGD:6480464 |
CTD |
| G |
Exo5 |
exonuclease 5 |
|
decreases expression |
ISO |
5 |
141,507,689 |
141,511,006 |
RGD:6480464 |
CTD |
| G |
Fam83d |
family with sequence similarity 83, member D |
|
multiple interactions |
ISO |
3 |
149,504,288 |
149,523,556 |
RGD:6480464 |
CTD |
| G |
Fam83d |
family with sequence similarity 83, member D |
|
decreases expression |
ISO |
3 |
149,504,288 |
149,523,556 |
RGD:6480464 |
CTD |
| G |
Foxc1 |
forkhead box C1 |
|
increases expression |
ISO |
17 |
39,026,186 |
39,030,163 |
RGD:6480464 |
CTD |
| G |
Foxc1 |
forkhead box C1 |
|
multiple interactions |
ISO |
17 |
39,026,186 |
39,030,163 |
RGD:6480464 |
CTD |
| G |
Gdf1 |
growth differentiation factor 1 |
|
increases expression |
ISO |
16 |
19,580,807 |
19,596,415 |
RGD:6480464 |
CTD |
| G |
Gdf1 |
growth differentiation factor 1 |
|
decreases expression |
ISO |
16 |
19,580,807 |
19,596,415 |
RGD:6480464 |
CTD |
| G |
Gdf5 |
growth differentiation factor 5 |
|
decreases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Gdpd3 |
glycerophosphodiester phosphodiesterase domain containing 3 |
|
multiple interactions |
ISO |
1 |
185,941,893 |
185,984,348 |
RGD:6480464 |
CTD |
| G |
Gdpd3 |
glycerophosphodiester phosphodiesterase domain containing 3 |
|
increases expression |
ISO |
1 |
185,941,893 |
185,984,348 |
RGD:6480464 |
CTD |
| G |
Haus5 |
HAUS augmin-like complex, subunit 5 |
|
multiple interactions |
ISO |
1 |
85,706,504 |
85,717,622 |
RGD:6480464 |
CTD |
| G |
Haus5 |
HAUS augmin-like complex, subunit 5 |
|
decreases expression |
ISO |
1 |
85,706,504 |
85,717,622 |
RGD:6480464 |
CTD |
| G |
Hist1h2bo |
histone cluster 1, H2bo |
|
multiple interactions |
ISO |
17 |
50,350,860 |
50,352,473 |
RGD:6480464 |
CTD |
| G |
Hist1h2bo |
histone cluster 1, H2bo |
|
decreases expression |
ISO |
17 |
50,350,860 |
50,352,473 |
RGD:6480464 |
CTD |
| G |
Hoxa11 |
homeobox A11 |
|
increases expression |
ISO |
4 |
80,542,417 |
80,546,079 |
RGD:6480464 |
CTD |
| G |
Hoxa9 |
homeobox A9 |
|
affects expression |
EXP |
4 |
80,524,246 |
80,526,491 |
RGD:6480464 |
CTD |
| G |
Hrct1 |
histidine rich carboxyl terminus 1 |
|
multiple interactions |
ISO |
5 |
60,212,808 |
60,213,544 |
RGD:6480464 |
CTD |
| G |
Hrct1 |
histidine rich carboxyl terminus 1 |
|
increases expression |
ISO |
5 |
60,212,808 |
60,213,544 |
RGD:6480464 |
CTD |
| G |
Hsh2d |
hematopoietic SH2 domain containing |
|
increases expression |
ISO |
16 |
18,060,515 |
18,072,470 |
RGD:6480464 |
CTD |
| G |
Hsh2d |
hematopoietic SH2 domain containing |
|
multiple interactions |
ISO |
16 |
18,060,515 |
18,072,470 |
RGD:6480464 |
CTD |
| G |
Kcnq5 |
potassium voltage-gated channel, KQT-like subfamily, member 5 |
|
affects expression |
ISO |
9 |
20,181,402 |
20,767,644 |
RGD:6480464 |
CTD |
| G |
Kif7 |
kinesin family member 7 |
|
multiple interactions |
ISO |
1 |
135,472,621 |
135,489,513 |
RGD:6480464 |
CTD |
| G |
Kif7 |
kinesin family member 7 |
|
decreases expression |
ISO |
1 |
135,472,621 |
135,489,513 |
RGD:6480464 |
CTD |
| G |
Kifc1 |
kinesin family member C1 |
|
multiple interactions |
ISO |
20 |
5,150,810 |
5,169,264 |
RGD:6480464 |
CTD |
| G |
Kifc1 |
kinesin family member C1 |
|
decreases expression |
ISO |
20 |
5,150,810 |
5,169,264 |
RGD:6480464 |
CTD |
| G |
Kntc1 |
kinetochore associated 1 |
|
multiple interactions |
ISO |
12 |
33,906,847 |
33,977,070 |
RGD:6480464 |
CTD |
| G |
Kntc1 |
kinetochore associated 1 |
|
decreases expression |
ISO |
12 |
33,906,847 |
33,977,070 |
RGD:6480464 |
CTD |
| G |
Lcorl |
ligand dependent nuclear receptor corepressor-like |
|
decreases expression |
ISO |
14 |
70,330,344 |
70,435,179 |
RGD:6480464 |
CTD |
| G |
Lcorl |
ligand dependent nuclear receptor corepressor-like |
|
multiple interactions |
ISO |
14 |
70,330,344 |
70,435,179 |
RGD:6480464 |
CTD |
| G |
LOC100158225 |
hypothetical protein LOC100158225 |
|
decreases expression |
ISO |
10 |
13,466,825 |
13,471,910 |
RGD:6480464 |
CTD |
| G |
LOC100158225 |
hypothetical protein LOC100158225 |
|
multiple interactions |
ISO |
10 |
13,466,825 |
13,471,910 |
RGD:6480464 |
CTD |
| G |
LOC100359600 |
karyopherin alpha 2-like |
|
multiple interactions |
ISO |
6 |
10,523,393 |
10,524,982 |
RGD:6480464 |
CTD |
| G |
LOC100359600 |
karyopherin alpha 2-like |
|
decreases expression |
ISO |
6 |
10,523,393 |
10,524,982 |
RGD:6480464 |
CTD |
| G |
LOC100360447 |
hypothetical protein LOC100360447 |
|
increases expression |
ISO |
1 |
179,509,477 |
179,576,475 |
RGD:6480464 |
CTD |
| G |
LOC100360447 |
hypothetical protein LOC100360447 |
|
multiple interactions |
ISO |
1 |
179,509,477 |
179,576,475 |
RGD:6480464 |
CTD |
| G |
LOC303566 |
E2F1-inducible gene |
|
decreases expression |
ISO |
10 |
91,329,706 |
91,347,594 |
RGD:6480464 |
CTD |
| G |
LOC303566 |
E2F1-inducible gene |
|
multiple interactions |
ISO |
10 |
91,329,706 |
91,347,594 |
RGD:6480464 |
CTD |
| G |
LOC498265 |
similar to hypothetical protein FLJ10706 |
|
multiple interactions |
ISO |
13 |
79,711,032 |
79,754,920 |
RGD:6480464 |
CTD |
| G |
LOC498265 |
similar to hypothetical protein FLJ10706 |
|
decreases expression |
ISO |
13 |
79,711,032 |
79,754,920 |
RGD:6480464 |
CTD |
| G |
LOC499331 |
similar to hypothetical protein D030056L22 |
|
multiple interactions |
ISO |
1 |
222,309,341 |
222,313,550 |
RGD:6480464 |
CTD |
| G |
LOC499331 |
similar to hypothetical protein D030056L22 |
|
decreases expression |
ISO |
1 |
222,309,341 |
222,313,550 |
RGD:6480464 |
CTD |
| G |
LOC500300 |
similar to hypothetical protein MGC6835 |
|
multiple interactions |
ISO |
4 |
153,000,782 |
153,002,562 |
RGD:6480464 |
CTD |
| G |
LOC500300 |
similar to hypothetical protein MGC6835 |
|
increases expression |
ISO |
4 |
153,000,782 |
153,002,562 |
RGD:6480464 |
CTD |
| G |
Ly96 |
lymphocyte antigen 96 |
|
multiple interactions |
ISO |
5 |
1,701,969 |
1,705,247 |
RGD:6480464 |
CTD |
| G |
Ly96 |
lymphocyte antigen 96 |
|
increases expression |
ISO |
5 |
1,701,969 |
1,705,247 |
RGD:6480464 |
CTD |
| G |
March11 |
membrane-associated ring finger (C3HC4) 11 |
|
multiple interactions |
ISO |
2 |
77,989,651 |
78,090,956 |
RGD:6480464 |
CTD |
| G |
March11 |
membrane-associated ring finger (C3HC4) 11 |
|
increases expression |
ISO |
2 |
77,989,651 |
78,090,956 |
RGD:6480464 |
CTD |
| G |
Mdc1 |
mediator of DNA damage checkpoint 1 |
|
decreases expression |
ISO |
20 |
3,042,953 |
3,057,607 |
RGD:6480464 |
CTD |
| G |
Mdc1 |
mediator of DNA damage checkpoint 1 |
|
multiple interactions |
ISO |
20 |
3,042,953 |
3,057,607 |
RGD:6480464 |
CTD |
| G |
MGC72627 |
similar to RIKEN cDNA A330021E22 |
|
increases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
MGC72627 |
similar to RIKEN cDNA A330021E22 |
|
multiple interactions |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Mgme1 |
mitochondrial genome maintenance exonuclease 1 |
|
multiple interactions |
ISO |
3 |
132,798,031 |
132,806,688 |
RGD:6480464 |
CTD |
| G |
Mgme1 |
mitochondrial genome maintenance exonuclease 1 |
|
decreases expression |
ISO |
3 |
132,798,031 |
132,806,688 |
RGD:6480464 |
CTD |
| G |
Mtbp |
Mdm2, transformed 3T3 cell double minute 2, p53 binding protein (mouse) binding protein, 104kDa |
|
multiple interactions |
ISO |
7 |
92,068,823 |
92,146,616 |
RGD:6480464 |
CTD |
| G |
Mtbp |
Mdm2, transformed 3T3 cell double minute 2, p53 binding protein (mouse) binding protein, 104kDa |
|
decreases expression |
ISO |
7 |
92,068,823 |
92,146,616 |
RGD:6480464 |
CTD |
| G |
Myh1 |
myosin, heavy chain 1, skeletal muscle, adult |
|
affects expression |
ISO |
10 |
53,894,388 |
53,917,948 |
RGD:6480464 |
CTD |
| G |
Myh1 |
myosin, heavy chain 1, skeletal muscle, adult |
|
multiple interactions |
ISO |
10 |
53,894,388 |
53,917,948 |
RGD:6480464 |
CTD |
| G |
Nek2l1 |
NIMA (never in mitosis gene a)-related kinase 2-like 1 |
|
decreases expression |
ISO |
8 |
14,245,342 |
14,246,673 |
RGD:6480464 |
CTD |
| G |
Nek2l1 |
NIMA (never in mitosis gene a)-related kinase 2-like 1 |
|
multiple interactions |
ISO |
8 |
14,245,342 |
14,246,673 |
RGD:6480464 |
CTD |
| G |
Nhsl1 |
NHS-like 1 |
|
affects expression |
ISO |
1 |
13,479,076 |
13,620,447 |
RGD:6480464 |
CTD |
| G |
Nr2c2ap |
nuclear receptor 2C2-associated protein |
|
multiple interactions |
ISO |
16 |
19,771,849 |
19,774,045 |
RGD:6480464 |
CTD |
| G |
Nr2c2ap |
nuclear receptor 2C2-associated protein |
|
decreases expression |
ISO |
16 |
19,771,849 |
19,774,045 |
RGD:6480464 |
CTD |
| G |
Nup133 |
nucleoporin 133 |
|
affects expression |
ISO |
19 |
54,089,391 |
54,139,882 |
RGD:6480464 |
CTD |
| G |
Ocel1 |
occludin/ELL domain containing 1 |
|
multiple interactions |
ISO |
16 |
18,532,477 |
18,534,246 |
RGD:6480464 |
CTD |
| G |
Ocel1 |
occludin/ELL domain containing 1 |
|
increases expression |
ISO |
16 |
18,532,477 |
18,534,246 |
RGD:6480464 |
CTD |
| G |
Parpbp |
PARP1 binding protein |
|
multiple interactions |
ISO |
7 |
24,777,634 |
24,847,083 |
RGD:6480464 |
CTD |
| G |
Parpbp |
PARP1 binding protein |
|
decreases expression |
ISO |
7 |
24,777,634 |
24,847,083 |
RGD:6480464 |
CTD |
| G |
Pcmtd1 |
protein-L-isoaspartate (D-aspartate) O-methyltransferase domain containing 1 |
|
decreases expression |
ISO |
5 |
12,362,759 |
12,401,359 |
RGD:6480464 |
CTD |
| G |
Piezo1 |
piezo-type mechanosensitive ion channel component 1 |
|
increases expression |
ISO |
19 |
52,770,967 |
52,834,347 |
RGD:6480464 |
CTD |
| G |
Plekhg6 |
pleckstrin homology domain containing, family G (with RhoGef domain) member 6 |
|
multiple interactions |
ISO |
4 |
162,185,519 |
162,201,845 |
RGD:6480464 |
CTD |
| G |
Plekhg6 |
pleckstrin homology domain containing, family G (with RhoGef domain) member 6 |
|
increases expression |
ISO |
4 |
162,185,519 |
162,201,845 |
RGD:6480464 |
CTD |
| G |
Ptplad1 |
protein tyrosine phosphatase-like A domain containing 1 |
|
decreases expression |
ISO |
8 |
69,243,485 |
69,264,608 |
RGD:6480464 |
CTD |
| G |
Ptprk |
protein tyrosine phosphatase, receptor type, K |
|
decreases expression |
ISO |
1 |
17,328,563 |
17,752,200 |
RGD:6480464 |
CTD |
| G |
Rad54l |
RAD54 like (S. cerevisiae) |
|
multiple interactions |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Rad54l |
RAD54 like (S. cerevisiae) |
|
decreases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Ralgapa2 |
Ral GTPase activating protein, alpha subunit 2 (catalytic) |
|
multiple interactions |
ISO |
3 |
134,867,846 |
135,145,583 |
RGD:6480464 |
CTD |
| G |
Ralgapa2 |
Ral GTPase activating protein, alpha subunit 2 (catalytic) |
|
increases expression |
ISO |
3 |
134,867,846 |
135,145,583 |
RGD:6480464 |
CTD |
| G |
Rbmxrtl |
RNA binding motif protein, X chromosome retrogene-like |
|
decreases expression |
ISO |
19 |
31,310,317 |
31,313,892 |
RGD:6480464 |
CTD |
| G |
Rbmxrtl |
RNA binding motif protein, X chromosome retrogene-like |
|
multiple interactions |
ISO |
19 |
31,310,317 |
31,313,892 |
RGD:6480464 |
CTD |
| G |
Relb |
v-rel reticuloendotheliosis viral oncogene homolog B |
|
multiple interactions |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Relb |
v-rel reticuloendotheliosis viral oncogene homolog B |
|
increases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Relb |
v-rel reticuloendotheliosis viral oncogene homolog B |
|
increases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
RGD1305834 |
similar to hypothetical protein FLJ11331 |
|
multiple interactions |
ISO |
2 |
224,818,192 |
224,877,373 |
RGD:6480464 |
CTD |
| G |
RGD1305834 |
similar to hypothetical protein FLJ11331 |
|
decreases expression |
ISO |
2 |
224,818,192 |
224,877,373 |
RGD:6480464 |
CTD |
| G |
RGD1306227 |
similar to 4833420G17Rik protein |
|
multiple interactions |
ISO |
2 |
51,642,381 |
51,664,029 |
RGD:6480464 |
CTD |
| G |
RGD1306227 |
similar to 4833420G17Rik protein |
|
decreases expression |
ISO |
2 |
51,642,381 |
51,664,029 |
RGD:6480464 |
CTD |
| G |
RGD1309104 |
similar to RIKEN cDNA 1700025G04 gene |
|
multiple interactions |
ISO |
13 |
66,786,043 |
66,955,550 |
RGD:6480464 |
CTD |
| G |
RGD1309104 |
similar to RIKEN cDNA 1700025G04 gene |
|
increases expression |
ISO |
13 |
66,786,043 |
66,955,550 |
RGD:6480464 |
CTD |
| G |
RGD1311739 |
similar to RIKEN cDNA 1700037H04 |
|
multiple interactions |
ISO |
3 |
118,851,409 |
118,865,511 |
RGD:6480464 |
CTD |
| G |
RGD1311739 |
similar to RIKEN cDNA 1700037H04 |
|
decreases expression |
ISO |
3 |
118,851,409 |
118,865,511 |
RGD:6480464 |
CTD |
| G |
RGD1359529 |
similar to chromosome 1 open reading frame 63 |
|
decreases expression |
ISO |
5 |
153,698,946 |
153,702,685 |
RGD:6480464 |
CTD |
| G |
RGD1560010 |
RGD1560010 |
|
multiple interactions |
ISO |
2 |
171,031,075 |
171,034,207 |
RGD:6480464 |
CTD |
| G |
RGD1560010 |
RGD1560010 |
|
decreases expression |
ISO |
2 |
171,031,075 |
171,034,207 |
RGD:6480464 |
CTD |
| G |
RGD1563365 |
similar to DNA segment, Chr 10, Wayne State University 102, expressed |
|
multiple interactions |
ISO |
7 |
22,498,460 |
22,524,191 |
RGD:6480464 |
CTD |
| G |
RGD1563365 |
similar to DNA segment, Chr 10, Wayne State University 102, expressed |
|
decreases expression |
ISO |
7 |
22,498,460 |
22,524,191 |
RGD:6480464 |
CTD |
| G |
RGD1563510 |
similar to RIKEN cDNA 8430427H17 gene |
|
multiple interactions |
ISO |
3 |
143,774,195 |
143,904,844 |
RGD:6480464 |
CTD |
| G |
RGD1563510 |
similar to RIKEN cDNA 8430427H17 gene |
|
increases expression |
ISO |
3 |
143,774,195 |
143,904,844 |
RGD:6480464 |
CTD |
| G |
RGD1563866 |
RGD1563866 |
|
multiple interactions |
ISO |
8 |
54,601,616 |
54,606,203 |
RGD:6480464 |
CTD |
| G |
RGD1563866 |
RGD1563866 |
|
decreases expression |
ISO |
8 |
54,601,616 |
54,606,203 |
RGD:6480464 |
CTD |
| G |
RGD1564036 |
similar to RIKEN cDNA 3010026O09 |
|
multiple interactions |
ISO |
10 |
35,724,312 |
35,751,257 |
RGD:6480464 |
CTD |
| G |
RGD1564036 |
similar to RIKEN cDNA 3010026O09 |
|
increases expression |
ISO |
10 |
35,724,312 |
35,751,257 |
RGD:6480464 |
CTD |
| G |
RGD1564149 |
similar to Protein C21orf58 |
|
multiple interactions |
ISO |
20 |
12,591,067 |
12,602,648 |
RGD:6480464 |
CTD |
| G |
RGD1564149 |
similar to Protein C21orf58 |
|
decreases expression |
ISO |
20 |
12,591,067 |
12,602,648 |
RGD:6480464 |
CTD |
| G |
Rmi1 |
RMI1, RecQ mediated genome instability 1, homolog (S. cerevisiae) |
|
multiple interactions |
ISO |
17 |
12,187,351 |
12,190,862 |
RGD:6480464 |
CTD |
| G |
Rmi1 |
RMI1, RecQ mediated genome instability 1, homolog (S. cerevisiae) |
|
decreases expression |
ISO |
17 |
12,187,351 |
12,190,862 |
RGD:6480464 |
CTD |
| G |
Rmi2 |
RMI2, RecQ mediated genome instability 2, homolog (S. cerevisiae) |
|
multiple interactions |
ISO |
10 |
4,765,965 |
4,771,062 |
RGD:6480464 |
CTD |
| G |
Rmi2 |
RMI2, RecQ mediated genome instability 2, homolog (S. cerevisiae) |
|
decreases expression |
ISO |
10 |
4,765,965 |
4,771,062 |
RGD:6480464 |
CTD |
| G |
Slc18b1 |
solute carrier family 18, subfamily B, member 1 |
|
decreases expression |
ISO |
1 |
22,201,424 |
22,255,955 |
RGD:6480464 |
CTD |
| G |
Slc18b1 |
solute carrier family 18, subfamily B, member 1 |
|
multiple interactions |
ISO |
1 |
22,201,424 |
22,255,955 |
RGD:6480464 |
CTD |
| G |
Slc41a1 |
solute carrier family 41, member 1 |
|
multiple interactions |
ISO |
13 |
44,766,706 |
44,777,526 |
RGD:6480464 |
CTD |
| G |
Slc41a1 |
solute carrier family 41, member 1 |
|
increases expression |
ISO |
13 |
44,766,706 |
44,777,526 |
RGD:6480464 |
CTD |
| G |
Smim14 |
small integral membrane protein 14 |
|
increases expression |
ISO |
14 |
45,477,213 |
45,520,785 |
RGD:6480464 |
CTD |
| G |
Smim14 |
small integral membrane protein 14 |
|
multiple interactions |
ISO |
14 |
45,477,213 |
45,520,785 |
RGD:6480464 |
CTD |
| G |
Spns2 |
spinster homolog 2 |
|
increases expression |
ISO |
10 |
59,335,327 |
59,374,485 |
RGD:6480464 |
CTD |
| G |
Srrm3 |
serine/arginine repetitive matrix 3 |
|
increases expression |
ISO |
12 |
21,927,594 |
22,005,675 |
RGD:6480464 |
CTD |
| G |
Srrm3 |
serine/arginine repetitive matrix 3 |
|
multiple interactions |
ISO |
12 |
21,927,594 |
22,005,675 |
RGD:6480464 |
CTD |
| G |
Sult1c3 |
sulfotransferase family, cytosolic, 1C, member 3 |
|
multiple interactions |
ISO |
9 |
486,576 |
531,962 |
RGD:6480464 |
CTD |
| G |
Sult1c3 |
sulfotransferase family, cytosolic, 1C, member 3 |
|
increases expression |
ISO |
9 |
486,576 |
531,962 |
RGD:6480464 |
CTD |
| G |
Tbc1d2 |
TBC1 domain family, member 2 |
|
increases expression |
ISO |
5 |
63,177,831 |
63,225,245 |
RGD:6480464 |
CTD |
| G |
Tbc1d2 |
TBC1 domain family, member 2 |
|
multiple interactions |
ISO |
5 |
63,177,831 |
63,225,245 |
RGD:6480464 |
CTD |
| G |
Tmem52 |
transmembrane protein 52 |
|
decreases expression |
ISO |
5 |
172,293,187 |
172,294,894 |
RGD:6480464 |
CTD |
| G |
Trex1 |
three prime repair exonuclease 1 |
|
multiple interactions |
ISO |
8 |
114,071,508 |
114,072,509 |
RGD:6480464 |
CTD |
| G |
Trex1 |
three prime repair exonuclease 1 |
|
decreases expression |
ISO |
8 |
114,071,508 |
114,072,509 |
RGD:6480464 |
CTD |
| G |
Trim59 |
tripartite motif-containing 59 |
|
multiple interactions |
ISO |
2 |
159,016,206 |
159,027,069 |
RGD:6480464 |
CTD |
| G |
Trim59 |
tripartite motif-containing 59 |
|
decreases expression |
ISO |
2 |
159,016,206 |
159,027,069 |
RGD:6480464 |
CTD |
| G |
Wbp1l |
WW domain binding protein 1-like |
|
increases expression |
ISO |
1 |
251,901,560 |
251,958,599 |
RGD:6480464 |
CTD |
| G |
Wbp1l |
WW domain binding protein 1-like |
|
multiple interactions |
ISO |
1 |
251,901,560 |
251,958,599 |
RGD:6480464 |
CTD |
| G |
Wsb1 |
WD repeat and SOCS box-containing 1 |
|
multiple interactions |
ISO |
10 |
65,427,131 |
65,443,208 |
RGD:6480464 |
CTD |
| G |
Wsb1 |
WD repeat and SOCS box-containing 1 |
|
decreases expression |
ISO |
10 |
65,427,131 |
65,443,208 |
RGD:6480464 |
CTD |
Term paths to the root
|